好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | P4 - Poster Session 04

Monday 04/15/24
11:45 AM - 12:45 PM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, 好色先生, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neurocritical Care, Neurohospitalist, Neuromuscular and Clinical Neurophysiology (EMG), Practice, Policy, and Ethics
View the latest research on a variety of topics. Posters are available in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Professionalism, Practice-based Learning and Improvement, Systems-based Practice
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive
Event Timeline
11:45 AM - 12:45 PM MDT Abstract 9-001 - Regional Brain 3R/4R RT-QuIC Seeding Reflects Patterns of AD Pathology and Correlates with Histopathological Burden of Disease
Varun S. Rachakonda, MD
11:45 AM - 12:45 PM MDT Abstract 9-002 - Feasibility of Using Blood-based Biomarkers to Evaluate the Effectiveness of Individualized Neurodegenerative Disease Preventive Care
Philip E. Sisser
11:45 AM - 12:45 PM MDT Abstract 9-003 - Comparing the Development of Post-stroke Depression Based on Location of Cerebral Artery Infarcts
Varun S. Rachakonda, MD
11:45 AM - 12:45 PM MDT Abstract 9-004 - Clinical and Neuroanatomical Characterization of the Semantic Behavioural Variant of Frontotemporal Dementia in a Multicentre Italian Cohort
Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM MDT Abstract 9-005 - Inflammatory Cytokines Profiles and Cognition Among Older Adults
Aline Thomas, PhD
11:45 AM - 12:45 PM MDT Abstract 9-006 - ANO6 Regulates Lipid Droplets in Astrocyte via Fatty Acid Uptake and Is Involved in Inflammation
Kexin Li, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 9-007 - Pathologic Changes in ELAVL3 Expression and Splicing Occur in TDP43 and Non-TDP43 Proteinopathies
Isabel Costantino, PhD
11:45 AM - 12:45 PM MDT Abstract 9-008 - Plasma GFAP in the Visual and Language Variants of Alzheimer’s Disease
Irene Sintini, PhD
11:45 AM - 12:45 PM MDT Abstract 9-009 - LesionBank.org: An Open Source Platform for Brain Lesion Case Reports
Joseph I. Turner
11:45 AM - 12:45 PM MDT Abstract 9-010 - A Case of Adult-onset MELAS as a Rapidly Progressive Dementia: Variant of Unknown Significance and the Importance of Neuropathologic Confirmation
Molly K. Wiggins, MD
11:45 AM - 12:45 PM MDT Abstract 9-011 - Pattern of Brain Structural Alternations Related to Deep Medullary Veins Injury
Zi-Yue Liu
11:45 AM - 12:45 PM MDT Abstract 9-012 - Associations of Liver Dysfunction with Incident Dementia, Cognition, and Brain Structure: A Prospective Cohort Study of 431,699 Adults
Ya-Nan Ou
11:45 AM - 12:45 PM MDT Abstract 9-013 - Association of a Multiplex Immune Marker Panel with Incident Cognitive Impairment and Dementia: The Northern Manhattan Study
Mohammad A. Sheikh, MBBS
11:45 AM - 12:45 PM MDT Abstract 9-014 - Comorbid Pathology in Clinical Trial Participants: Autopsy Findings and Clinical Features
Elif P. Coskun, MD
11:45 AM - 12:45 PM MDT Abstract 9-016 - Characterizing the Effects of Progranulin Reduction on Tau Pathology and Phenotypes in a Mouse Model of Tauopathy
Sanaea Z. Bhagwagar
11:45 AM - 12:45 PM MDT Abstract 9-017 - Characterizing Ligands that have Immunomodulatory Potential at the Choroid Plexus in Neurodegenerative Disease
Bhavya Bakshi
11:45 AM - 12:45 PM MDT Abstract 9-018 - Neuronal Intranuclear Inclusion Disease in New Zealand: A Novel Finding and Potential Polynesian Founder Effect
Tony Zhang, MBChB
11:45 AM - 12:45 PM MDT Abstract 15-001 - Impact of a Non-mydriatic Ocular Fundus Camera at a Quaternary Care Emergency Department
Valerie Biousse, MD
11:45 AM - 12:45 PM MDT Abstract 15-002 - Characteristics, Complications, and Outcomes of Critical Illness in Patients with Parkinson’s Disease.
Ori Lieberman, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 15-003 - Lumbar Puncture, Pneumocephalus, and a Transient Cranial Nerve Palsy: A Case Report
Anas Idris, MD
11:45 AM - 12:45 PM MDT Abstract 15-004 - Quality Assessment/Quality Improvement Measures for the Neurological Care of the Post Cardiac Arrest Patient at VA Pittsburgh Health Care System
Maria E. Baldwin, MD
11:45 AM - 12:45 PM MDT Abstract 3-001 - Constipation in Early-onset Parkinson’s Disease: Frequency, Time of Onset and Association with Mortality
Capucine Piat, MD
11:45 AM - 12:45 PM MDT Abstract 3-002 - Longitudinal Patterns of Depression and Anxiety in Parkinson Disease
Omolara Lawal, MD
11:45 AM - 12:45 PM MDT Abstract 3-003 - Association of Severe Hyposmia and Frontal Lobe Dysfunction in Patients with Parkinson’s Disease
Motohiro Okumura, MD
11:45 AM - 12:45 PM MDT Abstract 3-004 - Melanoma Risk and Timing of Parkinson Disease Diagnosis
James Searson
11:45 AM - 12:45 PM MDT Abstract 3-005 - Parkinson's Disease and Loneliness: An Initial Exploration
Tila Warner-Rosen
11:45 AM - 12:45 PM MDT Abstract 3-006 - Interim Analysis of Istradefylline Effects on Tremor in Parkinson's Disease Patients—Promising Benefits on Tremor Control
Irma Zhang
11:45 AM - 12:45 PM MDT Abstract 3-007 - Off-the-shelf Bioreactor Produced, iPSC-derived Neural Microtissues Containing Dopaminergic Neurons Innervate the Striatum and Normalize Behavior in a Parkinson Rat Model
Kevin Alessandri
11:45 AM - 12:45 PM MDT Abstract 3-008 - Comparing the NIH Toolbox-cognition Battery and Montreal Cognitive Assessment to Assess Cognitive Impairment in Patients with Parkinson Disease
Aashish Batheja
11:45 AM - 12:45 PM MDT Abstract 3-009 - Initiation of Apomorphine Hydrochloride Injection (Apokyn) in the Absence of an Antiemetic in People with Parkinson’s Disease
Cindy M. Happel, RN
11:45 AM - 12:45 PM MDT Abstract 3-010 - Exploring Knowledgeable Informant Reporting on the Earliest Changes of Parkinson’s Disease
Caroline M. Tanner, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-011 - Acceptability and Efficacy of a Novel Parkinson’s Care Partner Training Program
Jori Fleisher, MD, MSCE, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-012 - Sensitivity and Specificity of the Whistle-smile Reflex in Patients with Parkinson’s Disease
Mateus Damiani Monteiro, MD
11:45 AM - 12:45 PM MDT Abstract 3-013 - Comparison of Three Oral Amantadine Formulations: A Population Pharmacokinetic Study
Zhao Wang
11:45 AM - 12:45 PM MDT Abstract 3-015 - The Relationship Between Psychosis and Cognitive Function in Parkinson Disease
Nicole Bonsavage, MD
11:45 AM - 12:45 PM MDT Abstract 3-016 - Aerobic Fitness Is Associated with Better Cognitive and Motor Function in Mild-moderate Parkinson’s Disease
Ergun Y. Uc, MD
11:45 AM - 12:45 PM MDT Abstract 3-017 - Patient Characteristics and Real-world Use of Botulinum Toxins for Treatment of Chronic Sialorrhea
Michael Hast
11:45 AM - 12:45 PM MDT Abstract 3-018 - Cognitive Predictors of Quality of Life in Parkinson’s Disease: A Three-year Longitudinal Study
Katharine A. Henry, MD
11:45 AM - 12:45 PM MDT Abstract 3-019 - Optimizing a Patient’s Oral CD-LD Dosing Regimen Is Critical for Improving Efficacy in Parkinson’s Disease
Ghazal Banisadr, PhD
11:45 AM - 12:45 PM MDT Abstract 3-020 - Assessing Feasibility of Phone Video Data in Diagnosing Parkinsonism
Zahin Ahmed
11:45 AM - 12:45 PM MDT Abstract 12-001 - Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review
Rita Singh, PharmD
11:45 AM - 12:45 PM MDT Abstract 12-002 - Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-world Data of the Observational FINESSE Study
Mario Ortega, PhD
11:45 AM - 12:45 PM MDT Abstract 12-004 - Utilization of Health Care Resources and Sick Leave in a Large Cohort of Migraine Patients: A Real-world Data Analysis
Matanya Tirosh
11:45 AM - 12:45 PM MDT Abstract 12-005 - Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine
Charles E. Argoff, MD
11:45 AM - 12:45 PM MDT Abstract 12-006 - 6-month Real-world Effectiveness of Fremanezumab in Patients with Migraine who Switched from Another mAb Targeting the CGRP Pathway (Subgroup Analysis from FINESSE)
Verena Ramirez Campos, MD
11:45 AM - 12:45 PM MDT Abstract 12-007 - Comorbidity Rates in a Large Cohort of Patients with Migraine: A Real-world Data Analysis
Matanya Tirosh
11:45 AM - 12:45 PM MDT Abstract 12-008 - Real-world Switching Rates of Atogepant Are Lower than CGRP Monoclonal Antibodies (mAbs) in Patients with Migraine Using Claims Database
Karen Carr, PhD
11:45 AM - 12:45 PM MDT Abstract 12-009 - Characteristics of and Treatment Patterns Among Pediatric Patients with Post-traumatic Headache in a Pediatric Neurology Setting
Caroline Gentile Kruse, MD
11:45 AM - 12:45 PM MDT Abstract 12-010 - 好色先生 on Preventative Migraine Therapy Impacts Real-world Treatment Selection
Thomas Finnegan, Jr., PhD
11:45 AM - 12:45 PM MDT Abstract 6-001 - Attention to Sex as a Biological Variable in Phase III Neurological Trials Before and After the 2017 NIH Amendment: a Systematic Review in MS
Ayushi D. Balan
11:45 AM - 12:45 PM MDT Abstract 6-002 - Efficacy and Safety of Two Therapeutic Strategies in a Multiple Sclerosis Population of Afro-Caribbean Descent
Hugo Chaumont
11:45 AM - 12:45 PM MDT Abstract 6-003 - Ocrelizumab for Pediatric Relapsing Multiple Sclerosis
Malak AlMojel, MD
11:45 AM - 12:45 PM MDT Abstract 6-004 - VISIBL-MS: A Bilingual 好色先生al Tool to Increase Awareness of Early Multiple Sclerosis in Diverse Populations
Shivam Patel, MD
11:45 AM - 12:45 PM MDT Abstract 6-005 - Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates
Sophia Woodson
11:45 AM - 12:45 PM MDT Abstract 6-006 - Clinical Characteristics of Multiple Sclerosis in an Asian American Population
Manali S. Sheth, MD
11:45 AM - 12:45 PM MDT Abstract 6-007 - Performance of the 2023 Adult Criteria for the Radiologically Isolated Syndrome in Children and Comparison to the 2009 Criteria
Naila Makhani, MD
11:45 AM - 12:45 PM MDT Abstract 6-008 - Choroid Plexus Volume Disparities in Multiple Sclerosis Patients: A Comparative Analysis Between African American and Caucasian Cohorts
Carla E. Santiago-Martinez
11:45 AM - 12:45 PM MDT Abstract 6-009 - Pediatric-onset Multiple Sclerosis in Kuwait
Malak AlMojel, MD
11:45 AM - 12:45 PM MDT Abstract 6-010 - The Relationship Between Socioeconomic Status and Disability in MS Is Linked to Diet
Ilana B. Katz Sand, MD
11:45 AM - 12:45 PM MDT Abstract 6-011 - Novel Observations in the Management of Relapsing Non-syndromic Pediatric Tumefactive Demyelinating Lesions
Nikita Shukla, MD
11:45 AM - 12:45 PM MDT Abstract 6-012 - Healthcare Utilization Barriers in Multiple Sclerosis Patients Transitioning from Adolescent to Adult Care: A Multi-institutional Database Analysis in the United States
Trieste Francis
11:45 AM - 12:45 PM MDT Abstract 6-013 - Assessing Safety of High-efficacy Multiple Sclerosis Therapies in Elderly Patients
Juan I. Kenny, MD
11:45 AM - 12:45 PM MDT Abstract 6-014 - Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study
Madeleine Rose
11:45 AM - 12:45 PM MDT Abstract 6-015 - Safety of Discontinuing Disease-modifying Therapy in Aging MS Patients: A Single-center Study
Cori Polonski, MD
11:45 AM - 12:45 PM MDT Abstract 6-016 - Multiple Sclerosis in a Patient with Friedreich's Ataxia
Yang Yu, MD
11:45 AM - 12:45 PM MDT Abstract 6-017 - Effectiveness and Safety of High-efficacy Disease-modifying Therapy in Pediatric Multiple Sclerosis: A Retrospective Analysis at a Single Center
Rachel Walsh, MD
11:45 AM - 12:45 PM MDT Abstract 6-018 - Ethnic Disparities in the Incidence and Prevalence of Multiple Sclerosis
Gagana K. Mallawaarachchi
11:45 AM - 12:45 PM MDT Abstract 7-001 - Medical Student Narrative Evaluations of Resident Teachers: A Qualitative Study
Harry Sutherland, MD
11:45 AM - 12:45 PM MDT Abstract 7-002 - Simulation-based Training for Neurology and Neurosurgery Residents in ICU Procedures
Isha Snehal, MBBS
11:45 AM - 12:45 PM MDT Abstract 7-003 - A Qualitative Analysis of Communication-focused Feedback Provided to Child Neurology Residents During an Objective Structured Clinical Exam (OSCE)
Dara V. Albert, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 7-004 - Implementation of an Objective Structured Clinical Examination (OSCE) to Improve the Delivery of a Functional Neurological Disorder (FND) Diagnosis
Alana J. Kosches
11:45 AM - 12:45 PM MDT Abstract 7-005 - Qualitative Evaluation of an Interactive Art Intervention to Improve Resident Comfort with Working with Adults with Intellectual and Developmental Disabilities (IDD)
Jessica Sanders, MD
11:45 AM - 12:45 PM MDT Abstract 7-006 - Integrating Quality Improvement Curriculum and Group Projects: A Neurology Resident-Guided Initiative
Austin M. Saline, MD
11:45 AM - 12:45 PM MDT Abstract 7-007 - Effects of Implementation of a Night Float System in a Neurology Residency Program
Samantha McMahon, DO
11:45 AM - 12:45 PM MDT Abstract 7-008 - An Analysis of ACGME Resident Well-being Survey data and Its Correlation to a Resident-administered Well-being Survey
Lauren Bojarski, DO
11:45 AM - 12:45 PM MDT Abstract 1-001 - People with Epilepsy (PWE) and Attention Deficit Hyperactive Disorder (ADHD)/Attention Deficit Disorder (ADD)
Syed Muhammad Owais
11:45 AM - 12:45 PM MDT Abstract 1-002 - Increased Incidence of Comorbidities in Patients with Uncontrolled Epilepsy
Emily Klatte, MD
11:45 AM - 12:45 PM MDT Abstract 1-003 - Depression in Older Adults with Epilepsy: A Cross-sectional Study Examining Prevalence, Risk Factors, and Socio-demographic Correlates in the Detroit Metropolitan Geriatric Population
Maryam J. Syed, MBBS
11:45 AM - 12:45 PM MDT Abstract 1-004 - Clinical Importance of Anxiety Screening in Older Adults with Epilepsy
Jeongyeon Hwang, MD
11:45 AM - 12:45 PM MDT Abstract 1-006 - High Rates of Pregnancy Complications in Patients with Functional Seizures
Christina Catherine, MD
11:45 AM - 12:45 PM MDT Abstract 1-007 - Emergent C-section: Unusual Complication of Psychogenic Non-epileptic Spells
Estevao P. Ribeiro, MD
11:45 AM - 12:45 PM MDT Abstract 1-008 - Pregnancy Outcomes and Seizure Control in Underserved Patients with Epilepsy
Parisa Hassanzadeh, MD
11:45 AM - 12:45 PM MDT Abstract 1-009 - Differences in Delivery Type, Breastfeeding Initiation, and Length of Postpartum Hospitalization in Patients with Epilepsy within a Single Hospital System
Kelly Rios
11:45 AM - 12:45 PM MDT Abstract 1-010 - Progesterone-induced Cross-tolerance with Benzodiazepines in Some Women with Catamenial Epilepsy
Andrew G. Herzog, MD, MSc, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-011 - Pregnancy Outcomes Following Exposure to Lacosamide: Prospective Data from Spontaneous and Solicited Reports
Paula E. Voinescu, MD
11:45 AM - 12:45 PM MDT Abstract 1-012 - Highly Purified Cannabidiol (CBD) Use and Therapeutic Drug Monitoring in Pregnancy: A Case Report
Hrishikesh Dadhich, MD
11:45 AM - 12:45 PM MDT Abstract 1-013 - Are Recurrent Focal Seizures or Focal Status Epilepticus in Older Adults a Risk Factor for Early Mortality?
Abram Wahba, MD
11:45 AM - 12:45 PM MDT Abstract 1-014 - An Observational Study to Explore Burden of Epilepsy for Caregivers and Understand Perspectives of Health Care Providers in Argentina, China, and Taiwan
Ioannis Karakis, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-015 - Navigating Life after New-onset Refractory Status Epilepticus (NORSE) and Febrile-infection Related Epilepsy Syndrome (FIRES): Insights from Caregiver Interviews
Krista L. Eschbach, MD
11:45 AM - 12:45 PM MDT Abstract 1-016 - Analysis of Physician Notes to Examine the Clinical and Humanistic Burden of Patients with Dravet Syndrome and Lennox-Gastaut Syndrome in the United States
Satish C. Rao, MD, MS
11:45 AM - 12:45 PM MDT Abstract 10-001 - Eye Movement Characteristics of Congenital Myasthenic Syndromes
Ruben Jauregui, MD
11:45 AM - 12:45 PM MDT Abstract 10-004 - Clinician-reported Factors Influencing Performance of Cognitive Evaluations in Primary Care
Kyra O'Brien, MD
11:45 AM - 12:45 PM MDT Abstract 10-005 - Comparing how Antiseizure Medications are Publicly Regulated by Australia and New Zealand
Daniel P. Ashley, MPA
11:45 AM - 12:45 PM MDT Abstract 10-006 - Introduction of the Cultural Formulation Interview on the Inpatient Neurology Service
Vani Kumar
11:45 AM - 12:45 PM MDT Abstract 4-001 - In-house Diagnosis and Management of Peripheral Vertigo Patients, Where Do We Stand? An Adult Neurology Quality Improvement Study
Lobna A. Abdelwahab, MD
11:45 AM - 12:45 PM MDT Abstract 4-002 - Racial and Ethnic Disparities in the Incidence of Neuromyelitis Optica Spectrum Disorder
Angus Lee, DO
11:45 AM - 12:45 PM MDT Abstract 4-003 - Krabbe Disease Presenting As Combined Peripheral and Central Demyelinating Disease: A Case Report
Joshua T. Blotter, MD
11:45 AM - 12:45 PM MDT Abstract 4-004 - VHB937, a TREM2 Stabilizing and Activating Antibody Strongly Reduces Pathology After Peripheral Administration in a Broad Range of Animal Models for Neuroinflammation and Neurodegeneration
Martin Stangel, MD
11:45 AM - 12:45 PM MDT Abstract 4-005 - Adrenoleukodystrophy Masquerading as Chronic Immune Demyelinating Polyradiculoneuropathy in a Patient with HIV
Sarah Guistolisi, MD
11:45 AM - 12:45 PM MDT Abstract 4-006 - Low Vasopressin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Helena Huhmar
11:45 AM - 12:45 PM MDT Abstract 4-007 - A Decade of Deception: Wolfram Syndrome Masquerading as Multiple Sclerosis
Talha Ahmad
11:45 AM - 12:45 PM MDT Abstract 4-008 - A Combined Central and Peripheral Demyelination (CPPD) Syndrome After COVID-19 Vaccination
Lydia Kauffman, MD
11:45 AM - 12:45 PM MDT Abstract 4-009 - Prevalence and Characteristics of Patients with Both White Matter Disorders and Peripheral Neuropathy Due to Inherited Versus Acquired Causes
Malya Sahu, MD
11:45 AM - 12:45 PM MDT Abstract 4-010 - Differential Diagnosis of Leptomeningeal Enhancement in the Pediatric Population
Gabriela A. Bou, MD
11:45 AM - 12:45 PM MDT Abstract 4-011 - Two to Tango: Subacute Combined Degeneration with Encephalopathy due to Deficiency of B12 and Copper
Muhammad I. Yousaf, MD
11:45 AM - 12:45 PM MDT Abstract 4-012 - Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Doses of a Next Generation Prodrug Troriluzole in Healthy Subjects
Heather Sevinsky
11:45 AM - 12:45 PM MDT Abstract 4-013 - Troriluzole Exhibits Favorable Hepatic Safety Profile Across a Diverse Range of Disorders
Irfan Qureshi, MD
11:45 AM - 12:45 PM MDT Abstract 4-014 - No Clinically Relevant Effects of Hepatic Impairment on the Pharmacokinetics of a Next Generation Prodrug Troriluzole
Heather Sevinsky
11:45 AM - 12:45 PM MDT Abstract 13-002 - Mesiotemporal Involvement in Neurosyphilis
Joo Won Choi, MD
11:45 AM - 12:45 PM MDT Abstract 13-003 - Neurosyphilis in Disguise
Anas Idris, MD
11:45 AM - 12:45 PM MDT Abstract 13-005 - Dysautonomia Secondary to Progressive Tuberculous Meningitis in an Immunocompetent Patient Despite Antimicrobial Therapy
Raissa Aoun, MD
11:45 AM - 12:45 PM MDT Abstract 13-007 - Isoniazid-induced Peripheral Neuropathy: What’s the Effect of Concomitant Type-2 Diabetes Mellitus?
Manasvi Gupta
11:45 AM - 12:45 PM MDT Abstract 13-008 - Optochiasmatic Arachnoiditis - A Devastating Complication of Tuberculous Meningitis
Shanindra De Alwis, MD, MBBS
11:45 AM - 12:45 PM MDT Abstract 13-009 - Beyond the Lungs: Tuberculosis Unleashed – A Neurological Wake-up Call
Mohammad H. Almomani, MD
11:45 AM - 12:45 PM MDT Abstract 5-001 - Natural History of FGFR Gliomas
Maya Viera, Other
11:45 AM - 12:45 PM MDT Abstract 5-002 - Germline Fumarate Hydratase Mutations May be Associated with High-grade Gliomas and Mimic the Methylation Profile of IDH-mutant Gliomas
Sasmit Sarangi, MD, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-003 - Hypertonic Saline Solution Versus Mannitol for Brain Relaxation During Craniotomies: An Updated Meta-analysis
Artur Menegaz de Almeida, MS
11:45 AM - 12:45 PM MDT Abstract 5-004 - Metabolomic Approach to Identification of Prognostic Biomarkers of Glioblastoma
Orwa Aboud, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-005 - Pathogenic MUYTH and Novel H3F3A Variants in Glioblastoma: A Case Report and Literature Review
Ryan Rilinger
11:45 AM - 12:45 PM MDT Abstract 5-006 - Long-term Survival in a WHO Grade 4 IDH-mutant Astrocytoma Using a Farnesyltransferase Inhibitor in Combination with Temozolomide
Catherine Garcia, MD
11:45 AM - 12:45 PM MDT Abstract 5-007 - Selumetinib Halts Progression of Orbital/Periorbital Plexiform Neurofibromas in Neurofibromatosis Type 1
Ruben Jauregui, MD
11:45 AM - 12:45 PM MDT Abstract 5-008 - A Neural Implant for Cytostatic Hypothermia in Swine
Justine Ker, MD
11:45 AM - 12:45 PM MDT Abstract 5-009 - Novel Fusion GNAI2::BRAF as Driver for Pilocytic Astrocytoma: A Case Report
Maria A. Minor, MD
11:45 AM - 12:45 PM MDT Abstract 5-010 - Glioblastoma Multiforme Tumor Volume and Persistence of Chimeric Antigen Receptor T Cells Following Neurosurgical Debulking
Devi Veerappan
11:45 AM - 12:45 PM MDT Abstract 5-011 - Efficacy and Safety of Stereotactic Radiosurgery Versus Whole Brain Radiotherapy for the Management of Brain Metastasis: A Systematic Review and Meta-analysis
Ahmed Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-012 - Blood Neurofilament Light Chain Measurements in Adults with CNS Histiocytic Neoplasms
Samantha Banks, MD
11:45 AM - 12:45 PM MDT Abstract 5-013 - Disparities in Neuro-oncology: Highlighting Specific Target Areas for Improvement of Healthcare Disparities
Nara Michaelson, MD
11:45 AM - 12:45 PM MDT Abstract 5-014 - Differential Glioma Mortality and Grading in Disaggregated Asian American Subgroups: Insights from SEER 2000-2020
Shreya Gunda
11:45 AM - 12:45 PM MDT Abstract 5-015 - Neuro-oncological Research Output in the Middle East: A Scoping Review
Ibraheem Alkhawaldeh
11:45 AM - 12:45 PM MDT Abstract 5-016 - Neuro-oncological Research Output in Africa: A Scoping Review
Ahmed Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-017 - Smoking-related Genomic Alterations Are Observed in Patients with Glioma and May Contribute to Shortened Survival
Julia M. Landry
11:45 AM - 12:45 PM MDT Abstract 5-018 - Isolated Nervous System Histiocytic Neoplasms: Clinical Manifestations, Treatment, and Outcomes
Nabeela Nathoo, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-019 - Longitudinal Volumetric Analysis of FLAIR Hyperintensity Following Radiation Therapy (RT) in Patients with Low-grade Glioma (LGG)
Isabella Sutherland
11:45 AM - 12:45 PM MDT Abstract 5-021 - Urgent Caesarean Section Followed by Tumor Resection for Pregnancy-related Rapid Growth of WHO Grade 1 Pilocytic Astrocytoma
Diana M. Barratt, MD, MPH, FAAN
11:45 AM - 12:45 PM MDT Abstract 5-022 - Case Report of an Incidental Suprasellar Anaplastic Hemangiopericytoma
Michele Persico, MD
11:45 AM - 12:45 PM MDT Abstract 5-023 - Intravascular Lymphoma with Central Nervous System Involvement: Mayo Clinic Experience
Bryan J. Neth, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-024 - Clinical Characteristics and Treatment Approaches for H3K27-altered Diffuse Midline Glioma in Adolescents and Young Adults
Nupur Lala, MD
11:45 AM - 12:45 PM MDT Abstract 5-025 - Discrepancy in CSF Flow Cytometry Results from Lumbar Puncture and Ventricular Sampling Leading to Delay in Diagnosis Recurrent CNS Lymphoma: A Case Report
Neil Sielski, MD
11:45 AM - 12:45 PM MDT Abstract 5-026 - Evaluating Minimally Invasive Approaches to Meningioma Treatment
Varun S. Rachakonda, MD
11:45 AM - 12:45 PM MDT Abstract 5-027 - Lymphomatoid Granulomatosis: A Rare Lymphoproliferative Disorder on the Differential Diagnosis for Brain and Spinal Cord Lesions
Sneha Lingam, MD
11:45 AM - 12:45 PM MDT Abstract 5-029 - Cerebral Angiosarcoma and Distance Radiation Therapy
Ariana M. Frontario, DO
11:45 AM - 12:45 PM MDT Abstract 5-030 - Craniopharyngioma and Severe Hypercalcemia: Metabolic Derangements from Local Invasion
Michael E. Limia, MD
11:45 AM - 12:45 PM MDT Abstract 5-031 - A Rare Case of Multiple Brain Metastases from Urothelial Cancer: A Case Report
Darshil Shah, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-032 - A Rare Case of Primary Pineal Melanoma with Metastasis in an African American Patient
Micah Sy, MD
11:45 AM - 12:45 PM MDT Abstract 2-001 - Impact of Direct Outcome to a Comprehensive Epilepsy Center in Patients with Status Epilepticus
Julio A. Chalela, MD
11:45 AM - 12:45 PM MDT Abstract 2-002 - Patient Journey in Status Epilepticus: Understanding Treatment Pathways, Outcomes, and Health Care Burden Using Patient Level Hospital Data
Megan Barra
11:45 AM - 12:45 PM MDT Abstract 2-003 - VIGAB-STAT—A Phase IIa Feasibility Trial of Irreversible GABA-transaminase Inhibition as Adjunct Treatment of Status Epilepticus After Cardiac Arrest
Bakhtawar Ahmad, MBBS
11:45 AM - 12:45 PM MDT Abstract 2-005 - Improved Neuromonitoring for Critically Ill Patients Using Contextual Data
Samir D. Ruxmohan, DO
11:45 AM - 12:45 PM MDT Abstract 2-006 - Dosed to the Max—A Case Report About Bupropion Overdose
Ana Maria Roman, MD
11:45 AM - 12:45 PM MDT Abstract 11-001 - Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study
Ali A. Habib, MD
11:45 AM - 12:45 PM MDT Abstract 11-002 - Muscle-specific Tyrosine Kinase (MuSK) Autoantibody Measurement of More Than 53,000 Myasthenia Gravis Samples by Radioimmunoprecipitation Method in a Clinical Reference Laboratory Setting
Brandon Bauer
11:45 AM - 12:45 PM MDT Abstract 11-003 - Cost-effectiveness Analysis of Efgartigimod Versus Chronic Intravenous Immunoglobulin (IVIg) for Treatment of Acetylcholine Receptor Antibody Positive (AChR-Ab+) Generalized Myasthenia Gravis (gMG) in Canada
Zaeem A. Siddiqi, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 11-004 - Trial Design and Impact on Study Outcome: Post-hoc Analysis of the BeatMG Study Based on RINOMAX Trial Criteria
Bhaskar Roy, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-005 - First Cross-sectional Analysis from the ME&MGopen Study: A Decentralized Study on App-based Myasthenia Gravis
Clarissa Gorin, Other
11:45 AM - 12:45 PM MDT Abstract 11-006 - Digital Conversations by Myasthenia Gravis Serostatus
Raghav Govindarajan, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-007 - Ravulizumab Use for Acetylcholine Receptor-positive Generalized Myasthenia Gravis in Clinical Practice
Nakul Katyal, MD
11:45 AM - 12:45 PM MDT Abstract 11-008 - Improvement in Myasthenia Gravis Activities of Daily Living Subdomain Scores in Patients Treated with Eculizumab: Results from a Generalized Myasthenia Gravis Registry Study
Guido Sabatella
11:45 AM - 12:45 PM MDT Abstract 11-009 - A Real-life Experience with Eculizumab and Efgartigimod in Generalized Myasthenia Gravis Patients
Francesco Sacca, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-010 - Lack of Relationship Between Myasthenia Gravis and COVID-19 Severity
Christelle Haddad, MD
11:45 AM - 12:45 PM MDT Abstract 11-011 - Pre-diagnosis Predictors of High Health Care Cost Among Patients with Myasthenia Gravis Using a Combined Machine-learning and Regression Approach
Jacqueline Pesa
11:45 AM - 12:45 PM MDT Abstract 11-012 - Eculizumab Versus Rituxmab for Acetylcholine Receptor-positive Generalized Myasthenia Gravis: Single-center Experience
Hacer Durmus, MD
11:45 AM - 12:45 PM MDT Abstract 11-013 - Patient Preferences for Myasthenia Gravis Treatments: A Discrete-choice Experiment
Babak Boroojerdi, MD
11:45 AM - 12:45 PM MDT Abstract 11-014 - Clinical Effectiveness of Efgartigimod in Acetylcholine Receptor-positive Generalized Myasthenia Gravis
Alexis King
11:45 AM - 12:45 PM MDT Abstract 11-015 - Comorbidity Burden and Steroid Use in Generalized Myasthenia Gravis: A Retrospective Analysis of Medicare Fee-for-service Claims
Michael Blackowicz, PhD
11:45 AM - 12:45 PM MDT Abstract 11-016 - Incidence and Prevalence of Myasthenia Gravis: Analysis of a US Commercial Insurance Claims Database
Jennifer Schwinn
11:45 AM - 12:45 PM MDT Abstract 11-017 - Characteristics, Treatment Patterns, and Disease Burden of Juvenile Myasthenia Gravis in the United States
Frank Tennigkeit, PhD
11:45 AM - 12:45 PM MDT Abstract 11-018 - Diagnosis of Lambert-Eaton Myasthenic Syndrome (LEMS) May Be Missed Among Patients with Myasthenia Gravis and Autonomic Dysfunction: Results from a US Database Analysis
Steven Vernino, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-019 - Uncontrolled Myasthenia Gravis Can Contribute to Additional Stress Burden and Adverse Mental Health Experiences
Kelly G. Gwathmey, MD
11:45 AM - 12:45 PM MDT Abstract 11-020 - Can the Myasthenia Gravis Activities of Daily Life (MG-ADL) Score Predict Sleep Disturbance and Fatigue Among Patients with Myasthenia Gravis?
Christina Marini
11:45 AM - 12:45 PM MDT Abstract 14-001 - Describe the Clinical Course, Diagnostic Approach and Outcomes Following Thymectomy in Four Non-myasthenic Patients with Synaptic Antibody-mediated Autoimmune Neurologic Disease
Aditi Sharma, MBBS
11:45 AM - 12:45 PM MDT Abstract 14-002 - Interactions of Fcγ Receptors with an IgG4 Format, Anti-FcRn Monoclonal Antibody, Rozanolixizumab
Omar Qureshi
11:45 AM - 12:45 PM MDT Abstract 14-003 - Clinical Characterization of Neurofascin-155 IgG4 and Contactin-1 IgG Dual Positive Neuropathies
Shemonti Hasan, MD
11:45 AM - 12:45 PM MDT Abstract 14-004 - Climate Change Associated with Declining Clinical Outcomes in Myasthenia Gravis for US States with the Greatest Temperature Increase
Kazim Jaffry
11:45 AM - 12:45 PM MDT Abstract 14-005 - Neuromuscular Immune-related Adverse Events of Checkpoint Inhibitors. A Case Series at a Third-level Hospital in Argentina
Rodrigo Sanjinez, Sr., MD
11:45 AM - 12:45 PM MDT Abstract 14-006 - Successful Treatment of Concomitant Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome with Autologous CD19-targeted CAR-T Cells
Jeremias Motte, MD
11:45 AM - 12:45 PM MDT Abstract 14-007 - Evaluation of Autoantibody Status Effect on Dermatomyositis Patients’ Response to IVIG Treatment: Post-hoc Analysis of the ProDERM Trial
Mazen M. Dimachkie, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-008 - Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies
Nilufer Seth
11:45 AM - 12:45 PM MDT Abstract 14-010 - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Triggered by Reactivation of Chronic Hepatitis B Infection
Victoria Mazo, MD
11:45 AM - 12:45 PM MDT Abstract 14-011 - A Rare Case of Checkpoint Inhibitor-induced Myasthenia Gravis
Ifrah Waris, MD
11:45 AM - 12:45 PM MDT Abstract 14-012 - A Successful Treatment Story of a Patient with Immune Checkpoint Inhibitor Associated Myositis and Myasthenia Gravis
Jessica Frey, MD
11:45 AM - 12:45 PM MDT Abstract 14-013 - Characterization of the Earliest Adopters of Subcutaneous FcRn Blockers for gMG
Georgiana Kuhlmann
11:45 AM - 12:45 PM MDT Abstract 14-014 - Neurological Immune-related Adverse Events of Immune Checkpoint Inhibitors: A Single-center Retrospective Study
Luca Marsili, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 14-016 - Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-mediated Autoimmune Diseases
Tuan H. Vu, MD
11:45 AM - 12:45 PM MDT Abstract 14-017 - The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004)
Vera Bril, MD
11:45 AM - 12:45 PM MDT Abstract 14-018 - Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases
Julia Manasson, MD
11:45 AM - 12:45 PM MDT Abstract 14-019 - Subacute Inflammatory Demyelinating Polyneuropathy (SIDP) Secondary to Tumor Necrosis Factor (TNF)-Alpha Inhibitor (Adalimumab) for the Treatment of Rheumatoid Arthritis: A Case Report
Natalie Bartnik, DO
11:45 AM - 12:45 PM MDT Abstract 14-020 - Cerebrovascular Complications in Takayasu's Arteritis: A Middle Cerebral Artery Stroke Case Report
Samir D. Ruxmohan, DO
11:45 AM - 12:45 PM MDT Abstract 8-001 - Childhood Onset Amyotrophic Lateral Sclerosis Associated with SPTLC2 Gain-of-Function Pathogenic Variants: Clinical, Genetic, and Biochemical Insights
Rotem Orbach, MD
11:45 AM - 12:45 PM MDT Abstract 8-002 - The Impact of a Health Care Transition Clinic on Spina Bifida Condition Management and Transition Planning
Sujal Manohar, MD
11:45 AM - 12:45 PM MDT Abstract 8-003 - A Novel COL11A1 Variant in a Child with Neuromuscular Findings: Expanding the Genotypic and Phenotypic Spectrum of COL11A1-related Disease
Meghan McAnally, MD
11:45 AM - 12:45 PM MDT Abstract 8-005 - Phenotypic Variability of Seronegative Myasthenia Gravis in Children
Alexander J. Fay, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 8-006 - Dystrophinopathies in Children with Normal Creatinine Kinase Levels: A Case Series
Dhanalakshmi Angappan, MD
11:45 AM - 12:45 PM MDT Abstract 8-007 - Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44 Trial Design
Marc Morris, MD
Faculty Disclosures
Jennifer McGuire, MD Dr. McGuire has received research support from NIH.
David G. Coughlin, MD Dr. Coughlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. The institution of Dr. Coughlin has received research support from 好色先生. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
Heidi Standke No disclosure on file
Varun S. Rachakonda, MD Mr. Rachakonda has nothing to disclose.
Mikayla Huntley No disclosure on file
Caitlin Swanberg No disclosure on file
Thea Andreasson No disclosure on file
Yongya Kim No disclosure on file
Matteo Manca No disclosure on file
Olivia Thomas No disclosure on file
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Allison Kraus No disclosure on file
Anne E. Hiniker, MD Dr. Hiniker has nothing to disclose.
Alexander J. Gill, MD, PhD Dr. Gill has received personal compensation for serving as an employee of Novartis Pharmaceuticals Corporation. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society. Dr. Gill has a non-compensated relationship as a President, Treasurer, and Member of Board of Directors with Autoimmune Neurology Research Consortium, Inc. that is relevant to AAN interests or activities.
Kellyann Niotis, MD Dr. Niotis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with PAREF.
Alon Seifan, MD Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech.
Shannon Helfman Shannon Helfman has received personal compensation for serving as an employee of Institute for Neurodegenerative Diseases.
Praveen Parthasarathy Praveen Parthasarathy has nothing to disclose.
Hollie Hristov, NP Mrs. Hristov has nothing to disclose.
Juan Melendez-Herencia Juan Melendez-Herencia has nothing to disclose.
Christopher Janney Christopher Janney has received personal compensation for serving as an employee of Parkinson's Research & 好色先生 Foundation, Institute for Neurodegenerative Diseases. Christopher Janney has received intellectual property interests from a discovery or technology relating to health care.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Hanna Huber No disclosure on file
Nicholas Ashton No disclosure on file
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Philip E. Sisser Mr. Sisser has received personal compensation for serving as an employee of PAREF.
Helena Colvee Helena Colvee has nothing to disclose.
Jessica Lakis Jessica Lakis has nothing to disclose.
Kiarra Akiyoshi Kiarra Akiyoshi has nothing to disclose.
No disclosure on file
Anuttham Kandhadai Mr. Kandhadai has nothing to disclose.
Paul Brindley No disclosure on file
Dennis L. Kolson, MD, PhD The institution of Dr. Kolson has received research support from NIH--R01 research grant.
Alma Ghirelli No disclosure on file
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Silvia Basaia Silvia Basaia has nothing to disclose.
Veronica Castelnovo, MSc Dr. Castelnovo has nothing to disclose.
Giordano Cecchetti Giordano Cecchetti has nothing to disclose.
Elisa Sibilla Elisa Sibilla has nothing to disclose.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Paola Caroppo Paola Caroppo has nothing to disclose.
Sara Prioni Sara Prioni has nothing to disclose.
Cristina Villa No disclosure on file
Lucio Tremolizzo Lucio Tremolizzo has nothing to disclose.
Ildebrando H. Appollonio, MD Dr. Appollonio has nothing to disclose.
Federico Verde Federico Verde has nothing to disclose.
Nicola Ticozzi, MD The institution of Dr. Ticozzi has received research support from Italian Ministry of Health . The institution of Dr. Ticozzi has received research support from AriSLA.
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical services.
Aline Thomas, PhD Dr. Thomas has nothing to disclose.
Danurys Sanchez Danurys Sanchez has nothing to disclose.
Dolly Reyes-Dumeyer Dolly Reyes-Dumeyer has nothing to disclose.
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Anne C. Van Cott, MD, FAAN Dr. Van Cott has nothing to disclose.
Kexin Li, MD, PhD Dr. Li has nothing to disclose.
Lily Jan No disclosure on file
Chin-Fen Teo No disclosure on file
Huned S. Patwa, MD, FAAN No disclosure on file
John M. Ravits, MD, FAAN Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.
Isabel Costantino, PhD Ms. Costantino has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs.
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Neha Atulkumar Singh, PhD Dr. Singh has nothing to disclose.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Christopher Schwarz The institution of Christopher Schwarz has received research support from NIH.
Danni Li No disclosure on file
Juan Llibre No disclosure on file
Joseph I. Turner Mr. Turner has nothing to disclose.
Michael Ferguson Michael Ferguson has nothing to disclose.
Jared A. Nielsen, PhD Prof. Nielsen has nothing to disclose.
Anish Suvarna No disclosure on file
Vicky Chen No disclosure on file
Elijah Baughan No disclosure on file
Kiana Bunnell No disclosure on file
Frederic Schaper, MD, PhD Dr. Schaper has nothing to disclose.
Molly K. Wiggins, MD Dr. Wiggins has nothing to disclose.
Nikita Jain, MD Dr. Jain has nothing to disclose.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Amelia Kirby No disclosure on file
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
James R. Bateman III, MD, FAAN Dr. Bateman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView CME. Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EfficientCME. The institution of Dr. Bateman has received research support from NIA. The institution of Dr. Bateman has received research support from Dementia Alliance of North Carolina. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Drug Discovery Foundation. Dr. Bateman has a non-compensated relationship as a Committee Member with UCNS that is relevant to AAN interests or activities.
Zesong Yang No disclosure on file
Zi-Yue Liu Zi-Yue Liu has nothing to disclose.
Pei Wang Pei Wang has nothing to disclose.
Feifei Zhai No disclosure on file
Dong-Hui Ao No disclosure on file
Fei Han Fei Han has nothing to disclose.
Ming-Li Li No disclosure on file
Lixin Zhou Lixin Zhou has nothing to disclose.
Jun Ni Jun Ni has nothing to disclose.
Ming Yao Ming Yao has nothing to disclose.
Shu-Yang Zhang No disclosure on file
Liying Cui, PhD No disclosure on file
Zhengyu Jin No disclosure on file
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Jun Mu, MD, PhD No disclosure on file
Peiyang Gao Peiyang Gao has nothing to disclose.
Jintai Yu No disclosure on file
Lan Tan No disclosure on file
Ya-Nan Ou No disclosure on file
Mohammad A. Sheikh, MBBS Dr. Sheikh has nothing to disclose.
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Yeseon Moon No disclosure on file
Clinton B. Wright, MD, FAAN An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Wright has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Abali Milne Kalil. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Jose Gutierrez, MD Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Tatjana Rundek, MD, PhD The institution of Dr. Rundek has received research support from NIH.
Ken Cheung Ken Cheung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tsumura.
Mady Hornig No disclosure on file
Benjamin W. Friedman, MD, MS No disclosure on file
Elif P. Coskun, MD Dr. Coskun has nothing to disclose.
Justin Barber No disclosure on file
Erin Abner No disclosure on file
Richard Kryscio No disclosure on file
Frederick A. Schmitt, PhD The institution of Dr. Schmitt has received research support from NIH.
Linda Van Eldik No disclosure on file
Peter T. Nelson Peter T. Nelson has nothing to disclose.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Brian Gold No disclosure on file
Larry R. Faulkner, MD Dr. Faulkner has received personal compensation for serving as an employee of ABPN.
Fuling Yan No disclosure on file
Huiqing Wang No disclosure on file
Dorthea Juul, PhD Dr. Juul has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology.
Sanaea Z. Bhagwagar An immediate family member of Miss Bhagwagar has received personal compensation for serving as an employee of three different biotech companies unrelated to the present submission.
Hideyuki Takahashi No disclosure on file
Stephen M. Strittmatter, MD, PhD Dr. Strittmatter has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allyx. Dr. Strittmatter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proteowise. Dr. Strittmatter has stock in Allyx. Dr. Strittmatter has stock in Proteowise. Dr. Strittmatter has stock in ReNetX. The institution of Dr. Strittmatter has received research support from Proteowise. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care.
Abuhuzeifa Abubakr, MB, FRCP, FRCPI, FAAN No disclosure on file
Bhavya Bakshi Mr. Bakshi has nothing to disclose.
Michael Tiemeyer No disclosure on file
Katelyn Rosenbalm No disclosure on file
Tony Zhang, MBChB Dr. Zhang has nothing to disclose.
Neil Anderson, MD Dr. Anderson has nothing to disclose.
Jae Beom Hong, MBChB FRACP Dr. Hong has nothing to disclose.
Andrew M. Chancellor, MD, FRACP No disclosure on file
David O. Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Edward Wong, MD Dr. Wong has nothing to disclose.
Nicholas Child, MD Dr. Child has nothing to disclose.
Yi-Chu Liao, MD Dr. Liao has nothing to disclose.
Emma Glamuzina No disclosure on file
Yi-Chung Lee, MD, FAAN The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Jacqueline A. Nicholas, MD Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Aditi Sharma No disclosure on file
Tammy L. Smith, MD, PhD Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Melissa A. Wright, MD Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Jonathan R. Galli, MD Dr. Galli has nothing to disclose.
Robert Kadish, MD Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
M. M. Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Aaron L. Boster, MD Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Omar Qureshi No disclosure on file
Rosemary Bithell No disclosure on file
Rona Cutler No disclosure on file
Gillian McCluskey No disclosure on file
Graham Craggs No disclosure on file
Nicholas Barnes No disclosure on file
David Humphreys No disclosure on file
Stephen Rapecki No disclosure on file
Bryan Smith No disclosure on file
Anthony Shock Anthony Shock has received personal compensation for serving as an employee of UCB Pharma.
Gary A. Mellick, DO No disclosure on file
Shemonti Hasan, MD Dr. Hasan has nothing to disclose.
Haidara Kherbek Haidara Kherbek has nothing to disclose.
Pallab Sarker Pallab Sarker has nothing to disclose.
Yoonjae Nam No disclosure on file
Aaron L. Berkowitz, MD, PhD, FAAN Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill 好色先生. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
Alan D. Salgado, MD Dr. Salgado has nothing to disclose.
Kyle A. Wuthrich, DO Dr. Wuthrich has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
John R. Mills, MD, PhD The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Larry Mellick, MD No disclosure on file
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Scott Karpenos No disclosure on file
James Lin, MS Mr. Lin has nothing to disclose.
Justin Matos No disclosure on file
Kranthi K. Mandava Mr. Mandava has nothing to disclose.
Suhayb Islam Mr. Islam has nothing to disclose.
Narjis Jaffry No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
William Hamilton No disclosure on file
Rodrigo Sanjinez, Sr., MD Dr. Sanjinez has nothing to disclose.
Marcelo Rugiero Rodriguez Marcelo Rugiero Rodriguez has nothing to disclose.
Agustina Moroni Agustina Moroni has nothing to disclose.
Lucia Belen Varela Lucia Belen Varela has nothing to disclose.
Mariela Bettini, MD Dr. Bettini has nothing to disclose.
Facundo Silveira No disclosure on file
Pablo Sosa No disclosure on file
Carolina L. Azcona, MD Dr. Azcona has nothing to disclose.
Rocio V. Marquez, MD Dr. Marquez has nothing to disclose.
Jeremias Motte, MD The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Melissa Sgodzai Melissa Sgodzai has nothing to disclose.
Christiane Schneider-Gold No disclosure on file
Dominic Borie Dominic Borie has received personal compensation for serving as an employee of Kyverna Therapeutics. Dominic Borie has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Kyverna Therapeutics. Dominic Borie has stock in Kyverna.
Tobias Hegelmaier Tobias Hegelmaier has nothing to disclose.
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Dimitrios Mougiakakos Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna Therapeutics. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Interius Bio. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AvenCell. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beigene. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite/Gilead. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Roland Schroers Roland Schroers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KYVERNA.
Rohit Aggarwal, MD Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Christina Charles-Schoeman Christina Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Christina Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Christina Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sana Biotechnology. Christina Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recludix. Christina Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingleheim. Christina Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Christina Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galapagos. Christina Charles-Schoeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Christina Charles-Schoeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Christina Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recludix. Christina Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sana Biotechnologies.
Joachim Schessl Joachim Schessl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma.
Elisabeth Clodi, PhD Dr. Clodi has received personal compensation for serving as an employee of Octapharma Pharmazeutika Produktionsges.m.b.H..
Warren D. Lo, MD, FAAN The institution of Dr. Lo has received research support from NIH. Dr. Lo has received publishing royalties from a publication relating to health care.
Nilufer Seth No disclosure on file
Rui Xu No disclosure on file
Leona Ling, PhD Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.
Traymon Beavers No disclosure on file
Viraj Parge No disclosure on file
Steven Tyler No disclosure on file
William Avery William Avery has stock in Nuvig Therapeutics.
Sam Sihapong No disclosure on file
Julia Brown No disclosure on file
Sindhu Ramchandren, MD Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Hong Sun, MD, PhD Dr. Sun has received personal compensation for serving as an employee of Janssen.
Kristin Heerlein, MD, PhD Dr. Heerlein has received personal compensation for serving as an employee of Johnson and Johnson Innovative Medicine. Dr. Heerlein has stock in Johnson and Johnson Innovative Medicine.
Katie Abouzahr No disclosure on file
Sayak Bhattacharya No disclosure on file
Monika Mishra, MD Dr. Mishra has nothing to disclose.
Henk-Andre A. Kroon, MD, MBA Dr. Kroon has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Kroon has stock in Annexon Biosciences.
Kunal Kanani No disclosure on file
Eric Humphriss Eric Humphriss has received personal compensation for serving as an employee of Annexon Biosciences. Eric Humphriss has stock in Annexon Biosciences.
Preeti Paliwal No disclosure on file
Benjamin Hoehn Benjamin Hoehn has received personal compensation for serving as an employee of Annexon.
Christos Stylianou No disclosure on file
Zhahirul Islam Zhahirul Islam has nothing to disclose.
Nowshin Papri No disclosure on file
Quazi Deen Mohammad, MD Dr. Deen Mohammad has nothing to disclose.
AJ Acker No disclosure on file
Lily Parker No disclosure on file
Naveen Perisetla No disclosure on file
Victoria Mazo, MD Dr. Mazo has nothing to disclose.
Natasha N. Llanes, MD Dr. Llanes has nothing to disclose.
Anthony M. Bradshaw, MD Dr. Bradshaw has nothing to disclose.
Vishunmurthy S. Hedna, MD No disclosure on file
Axel M. Baez-Lugo, MD Dr. Baez-Lugo has nothing to disclose.
Ifrah Waris, MD Ms. Waris has nothing to disclose.
Anusha Gadipudi, MD Miss Gadipudi has nothing to disclose.
Ashley Vincenty-Acosta, MD Miss Vincenty-Acosta has nothing to disclose.
Gerald Wallace IV, MD Dr. Wallace has nothing to disclose.
Ivan Adamec Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jadran Galenski laboratorij. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Phoenix farmacija.
Hongxuyang Yu, MD Dr. Yu has nothing to disclose.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Andrew Beiter No disclosure on file
Magdalena Krbot Skoric Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Blaine Cloud, PhD Dr. Cloud has nothing to disclose.
Georgiana Kuhlmann Georgiana Kuhlmann has stock in Amgen.
Mario Habek, MD Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Luca Marsili, MD, PhD Dr. Marsili has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IAPRD. Dr. Marsili has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia.
Kevin Duque, MD Dr. Duque has nothing to disclose.
Samuel B. Marcucci, MD The institution of Mr. Marcucci has received research support from Foundation of the Consortium of Multiple Sclerosis Centers.
Martina Chirra No disclosure on file
Joseph C. LaPorta Mr. LaPorta has nothing to disclose.
Jesus Abanto Mr. Abanto has received personal compensation for serving as an employee of University of Cincinnati .
Alberto Vogrig, MD, PhD Dr. Vogrig has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Vogrig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. The institution of Dr. Vogrig has received research support from Ministero della Salute, Bando Ricerca Finalizzata.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Ahmed Ibrahim, MBBCH Dr. Ibrahim has nothing to disclose.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Dusan Stefoski, MD, FAAN No disclosure on file
Tuan H. Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Catherine Broome No disclosure on file
Matthias Goebeler No disclosure on file
Hiroyuki Murai, MD Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Zsuzsanna Bata-Csorgo No disclosure on file
Adrian Newland No disclosure on file
Peter Ulrichts Peter Ulrichts has received personal compensation for serving as an employee of argenx. Peter Ulrichts has stock in argenx.
Rene Kerstens No disclosure on file
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Sofiane Agha No disclosure on file
Ming Jiang No disclosure on file
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Artur Druzdz Artur Druzdz has nothing to disclose.
Julian Grosskreutz Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Henry J. Kaminski, MD, FAAN Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Sabrina Sacconi, MD Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
Kimiaki Utsugisawa, MD, PhD Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Marion Boehnlein Marion Boehnlein has stock in UCB.
Franz Woltering No disclosure on file
Bernhard Greve, MD Dr. Greve has received personal compensation for serving as an employee of UCB Biosciences. Dr. Greve has stock in UCB Biosciences.
Maryam Gayfieva No disclosure on file
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Ivan Mascanfroni No disclosure on file
Julia Manasson, MD Dr. Manasson has received personal compensation for serving as an employee of Seismic Therapeutic. Dr. Manasson has stock in Seismic Therapeutic. The institution of Dr. Manasson has received research support from Rheumatology Research Foundation.
Alex Pellerin No disclosure on file
Liliana Sanmarco No disclosure on file
Jordan Anderson No disclosure on file
Nathan Rollins No disclosure on file
Andita Newton No disclosure on file
Ryan Peckner No disclosure on file
Yi Xing No disclosure on file
Nathan Higginson-Scott No disclosure on file
John Sundy, MD, PhD No disclosure on file
Kevin Otipoby No disclosure on file
Katherine A. Riester, MPH No disclosure on file
Natalie Bartnik, DO Dr. Bartnik has nothing to disclose.
Mark Grady, MD Dr. Grady has nothing to disclose.
Laith N. Maali, MD Dr. Maali has nothing to disclose.
Sean T. Beattie, DO Dr. Beattie has nothing to disclose.
Jacob S. Elkins, MD No disclosure on file
Jonathan Quinonez No disclosure on file
Samir D. Ruxmohan, DO Dr. Ruxmohan has nothing to disclose.
Juliana Cazzaniga Miss Cazzaniga has nothing to disclose.
Rotem Orbach, MD Dr. Orbach has nothing to disclose.
Safoora B. Syeda, MBBS No disclosure on file
Payam Mohassel, MD Dr. Mohassel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics LLC. Dr. Mohassel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mohassel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Carr Maloney PC. Dr. Mohassel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SARNO DA COSTA D'ANIELLO MACERI WEBB ATTORNEYS AT LAW. The institution of Dr. Mohassel has received research support from NIH-- K22. The institution of Dr. Mohassel has received research support from DoD. The institution of Dr. Mohassel has received research support from Million Dollar Bike Ride UPenn. The institution of Dr. Mohassel has received research support from NIH-- R01. The institution of Dr. Mohassel has received research support from Packard Center for ALS Research. The institution of Dr. Mohassel has received research support from Live Like Lou Foundation. The institution of Dr. Mohassel has received research support from Maryland Stem Cell Research Fund. Dr. Mohassel has received personal compensation in the range of $0-$499 for serving as a CME Honorarium as Writer with MedLink Neurology. Dr. Mohassel has a non-compensated relationship as a Scientific Advisory Board Member with RYR1 Foundation that is relevant to AAN interests or activities. Dr. Mohassel has a non-compensated relationship as a Editorial Board member with Neuromuscular Disorders (Journal) that is relevant to AAN interests or activities. Dr. Mohassel has a non-compensated relationship as a Editorial Board member with Journal of Neuromuscular Diseases that is relevant to AAN interests or activities.
Maike Dohrn, MD Dr. Dohrn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea, Alnylam, Pfizer, Amicus. Dr. Dohrn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus, Akcea. Dr. Dohrn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea, Alnylam, Pfizer. The institution of Dr. Dohrn has received research support from Pfizer. Dr. Dohrn has received research support from German Research Foundation.
Museer Lone No disclosure on file
Sandra Donkervoort Ms. Donkervoort has nothing to disclose.
A. Reghan Foley, MD A. Reghan Foley has nothing to disclose.
Danique Beijer, PhD Dr. Beijer has nothing to disclose.
Elif Bayraktar No disclosure on file
Piraye Oflazer No disclosure on file
Pinki Munot No disclosure on file
Aubrey Rose No disclosure on file
Michael Lyons No disclosure on file
Raymond Louie No disclosure on file
Kenneth Gable No disclosure on file
MARCONDES CAVALCANTE FRANCA No disclosure on file
Juan E. Galarza-Brito II, MD Dr. GALARZA-BRITO has nothing to disclose.
Matthias Eckenweiler No disclosure on file
Alexander Asamoah No disclosure on file
Anirban Majumdar No disclosure on file
Perry Shieh, MD, PhD, FAAN Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Anke Schumann No disclosure on file
Sita Gupta No disclosure on file
Arpita Lakhotia, MD, FAAN Dr. Lakhotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Kelly Jackson No disclosure on file
Katherine Chao No disclosure on file
Thomas L. Winder, PhD, FACMG Dr. Winder has nothing to disclose.
Francesco Catapano No disclosure on file
Lucy Feng No disclosure on file
Janbernd Kirschner No disclosure on file
Sitong Chen No disclosure on file
Matt Danzi Matt Danzi has nothing to disclose.
Matthis Synofzik Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Nazli Basak No disclosure on file
Teresa Dunn No disclosure on file
Thorsten Hornemann No disclosure on file
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Carsten G. Bonnemann, MD Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with RYR1 Foundation that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Genethon that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Sarepta Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Kate Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with CureCMD that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Seal Therapeutics that is relevant to AAN interests or activities.
Bilal Berke Ayvaz, MD Dr. Ayvaz has nothing to disclose.
Sema Saltik No disclosure on file
Fitnat Ulug No disclosure on file
Serhat Guler No disclosure on file
Meghan McAnally, MD Dr. McAnally has nothing to disclose.
Abigail Potticary Abigail Potticary has nothing to disclose.
Ying Hu No disclosure on file
Laryssa Huryn No disclosure on file
Lynn Pais No disclosure on file
Amanda Cyntia Lima Fonseca Rodrigues Ms. Rodrigues has nothing to disclose.
Alexander J. Fay, MD, PhD Dr. Fay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Retrotope. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Teladoc. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeglea. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curry Rockefeller Group. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspiro. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dwyer Hernandez. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gallagher Bassett. Dr. Fay has received research support from Sarepta. The institution of Dr. Fay has received research support from Preston-Werner Ventures.
Jonathan B. Strober, MD Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Strober has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. Dr. Strober has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Many Law Firms. The institution of Dr. Strober has received research support from Anonymous. The institution of Dr. Strober has received research support from PTC. The institution of Dr. Strober has received research support from Fibrogen. The institution of Dr. Strober has received research support from Jansen. The institution of Dr. Strober has received research support from Biohaven.
Dhanalakshmi Angappan, MD Dr. Angappan has nothing to disclose.
Erika L. Finanger, MD Dr. Finanger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. Finanger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Finanger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Finanger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Mark C. Stahl, MD, PhD Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Elizabeth J. Ackermann, PhD Dr. Ackermann has received personal compensation for serving as an employee of Avidity Biosciences.
Yiming Zhu, PhD Dr. Zhu has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Zhu has stock in Avidity Biosciences.
Steven G. Hughes Steven G. Hughes has received personal compensation for serving as an employee of Avidity Biosciences. Steven G. Hughes has received personal compensation for serving as an employee of Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ionis Pharmaceuticals. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avidity Biosciences. Steven G. Hughes has stock in Arcturus Therapeutics. Steven G. Hughes has stock in Avidity Biosciences.
Yvonne Tami Yvonne Tami has received personal compensation for serving as an employee of Avidity Biosciences. Yvonne Tami has or had stock in Avidity Biosciences.
Chamindra G. Laverty, MD The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Man Mohan Mehndiratta, MD, MBBS, FAAN Dr. Mehndiratta has nothing to disclose.
Harry Sutherland, MD Dr. Sutherland has received publishing royalties from a publication relating to health care.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Sara M. Schaefer, MD, FAAN Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. The institution of Dr. Schaefer has received research support from American Parkinson Disease Association. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a RITE Section Lead with 好色先生. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a QOD Question Writer with 好色先生.
Joseph Benes, MD Dr. Benes has nothing to disclose.
Isha Snehal, MBBS Dr. Snehal has nothing to disclose.
Subin Mathew, MD Dr. Mathew has nothing to disclose.
Daryl R. Gress, MD, FAAN Dr. Gress has nothing to disclose.
Makayla Schissel No disclosure on file
Sanjay Pandey, MD Dr. Pandey has nothing to disclose.
Cindy Ho Ms. Ho has nothing to disclose.
Dara V. Albert, DO, FAAN Dr. Albert has nothing to disclose.
Pedro Weisleder, MD, PhD, FAAN Dr. Weisleder has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
Margie A. Ream, MD, PhD, FAAN Dr. Ream has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebird Bio. Dr. Ream has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Council for Neurologic Subspecialties. Dr. Ream has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Rushton, Stakely, Johnston & Garrett, P.A. . Dr. Ream has received personal compensation in the range of $10,000-$49,999 for serving as a Evidence Review Group member with Health Resources and Services Administration. Dr. Ream has received personal compensation in the range of $0-$499 for serving as a Organizational representative with Child Neurology Society.
Alana J. Kosches Ms. Kosches has nothing to disclose.
Kiara Stanifer No disclosure on file
Nuri Jacoby, MD, FAAN Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Jessica Sanders, MD The institution of Dr. Sanders has received research support from Child Neurology Foundation. The institution of Dr. Sanders has received research support from NIH. The institution of Dr. Sanders has received research support from HRSA.
Ashley Dafoe No disclosure on file
Brooke Dorsey Holliman No disclosure on file
Austin M. Saline, MD Dr. Saline has nothing to disclose.
Varun Pandya, MD Dr. Pandya has nothing to disclose.
Ketevan Amirkhanashvili, MD Dr. Amirkhanashvili has nothing to disclose.
Sally S. Ladsaria, MD Dr. Ladsaria has nothing to disclose.
Thomas Draper, MD Dr. Draper has nothing to disclose.
Liane E. Hunter, MD, PhD Dr. Hunter has nothing to disclose.
Lauren Gluck, MD Dr. Gluck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeautics. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Rare Disease. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Mark Milstein, MD, FAAN Dr. Milstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Milstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Milstein has received publishing royalties from a publication relating to health care. Dr. Milstein has a non-compensated relationship as a Board of Directors with New York County Medical Society that is relevant to AAN interests or activities.
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Samantha McMahon, DO Dr. McMahon has nothing to disclose.
Lauren Koffman, DO, MS Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm. Dr. Koffman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Walters Kluwer.
Louis Goodrich, DO Dr. Goodrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Ching Tsao, MD Dr. Tsao has nothing to disclose.
Lauren Bojarski, DO Dr. Bojarski has nothing to disclose.
Timothy J. Ainger, PhD Dr. Ainger has nothing to disclose.
Syed Muhammad Owais Mr. Owais has nothing to disclose.
Fahham Asghar, MD Mr. Asghar has nothing to disclose.
Hira Pervez, MD, MBBS Dr. Pervez has nothing to disclose.
Sidra Saleem, MD Dr. Saleem has nothing to disclose.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Naeem Mahfooz, MD Dr. Mahfooz has nothing to disclose.
Joyeta Razzaque, MBBS Dr. Razzaque has nothing to disclose.
Rabia Zubair, MD Dr. Zubair has nothing to disclose.
Bashar Saour, MD Dr. Saour has nothing to disclose.
Anum H. Riaz, MD Dr. Riaz has nothing to disclose.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Sumayya Naz, MD Dr. Naz has nothing to disclose.
R E. Faught, Jr., MD, FAAN Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Wesley Kerr, MD, PhD Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from 好色先生. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Emily Klatte, MD Dr. Klatte has received personal compensation in the range of $0-$499 for serving as a Consultant for SK Life Science . Dr. Klatte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis, Inc. Dr. Klatte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis.
Clarence Wade Clarence Wade has nothing to disclose.
Sean Stern Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Maryam J. Syed, MBBS Dr. Syed has nothing to disclose.
Jeongyeon Hwang, MD Dr. Hwang has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Rohit A. Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Kaylie Kaneshiro No disclosure on file
Keith S. Yamamoto Dr. Yamamoto has nothing to disclose.
Liza Rooks Ms. Rooks has nothing to disclose.
Johanna Mandl No disclosure on file
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Julia Jahansooz Julia Jahansooz has nothing to disclose.
Stephen A. McGuire, MD, FAAN No disclosure on file
Christina Catherine, MD Dr. Catherine has nothing to disclose.
Janet F. Waters, MD, FAAN An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Haemonetics. An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haemonetics. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Vitalant. An immediate family member of Dr. Waters has received publishing royalties from a publication relating to health care.
Alexandra Urban, MD, FAAN Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Philion Gatchoff, MD Dr. Gatchoff has nothing to disclose.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Estevao P. Ribeiro, MD Dr. Ribeiro has nothing to disclose.
Evan Fields, MD Dr. Fields has nothing to disclose.
Anna Serafini, MD Dr. Serafini has nothing to disclose.
Elizabeth Cunningham Elizabeth Cunningham has nothing to disclose.
Alexa M. King, MD Dr. King has received research support from American Neurologic Association. The institution of Dr. King has received research support from Esai Pharmaceuticals.
Elizabeth Gerard, MD Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care.
Assia Meziane-Tani, MD No disclosure on file
Alexandra Moise, MD Dr. Moise has nothing to disclose.
Parisa Hassanzadeh, MD Dr. Hassanzadeh has nothing to disclose.
Kelly Rios Ms. Rios has nothing to disclose.
Anumeha S. Sheth, MBBS Dr. Sheth has nothing to disclose.
Sarah Lindsay No disclosure on file
Andrew G. Herzog, MD, MSc, FAAN Dr. Herzog has nothing to disclose.
Piero Perucca, MD The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Perucca has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Epilepsy Foundation. The institution of Dr. Perucca has received research support from Monash University. The institution of Dr. Perucca has received research support from Sanming Project Grant, Shenzhen government. The institution of Dr. Perucca has received research support from Medical Research Future Fund. The institution of Dr. Perucca has received research support from Norman Beischer Medical Research Foundation. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation. The institution of Dr. Perucca has received research support from The University of Melbourne and The University of Bonn. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation . Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Eisai. Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as a Speaker with UCB. Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as a Speaker with LivaNova. Dr. Perucca has a non-compensated relationship as a Member, Central Project Commission with EURAP-International Registry of Antiepileptic Drugs and Pregnancy that is relevant to AAN interests or activities. Dr. Perucca has a non-compensated relationship as a Member, Advisory Board with Raoul Wallenberg Australian Pregnancy Register of Antiepileptic Drugs that is relevant to AAN interests or activities.
Dimitrios Bourikas Dr. Bourikas has nothing to disclose.
Paula E. Voinescu, MD The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a PhD Opponent with University of Bergen, Norway. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Lata Vadlamudi, MD, MBBS The institution of Dr. Vadlamudi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Vadlamudi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Daya Chellun No disclosure on file
Thomas Kumke No disclosure on file
Konrad Werhahn Konrad Werhahn has received personal compensation for serving as an employee of UCB Pharma. Konrad Werhahn has stock in UCB Pharma.
Bettina Schmitz No disclosure on file
Tyler E. Gaston, MD Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
Hrishikesh Dadhich, MD Dr. Dadhich has nothing to disclose.
Diosely C. Silveira, MD, PhD, FAAN Dr. Silveira has nothing to disclose.
Abram Wahba, MD Dr. Wahba has nothing to disclose.
Michelle Lucena No disclosure on file
Michelle Ganat, MD Dr. Ganat has nothing to disclose.
Raquel Romero, MD Dr. Romero has nothing to disclose.
Ioannis Karakis, MD, FAAN Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Santiago Flesler Santiago Flesler has nothing to disclose.
Meng Han Tsai, MD Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for GSK. The institution of Dr. Tsai has received research support from National Heath Research Institute. The institution of Dr. Tsai has received research support from National Science Technology Council.
Ovi Ghorpade No disclosure on file
Rio Carla Pineda No disclosure on file
Kalpesh Joshi No disclosure on file
James Cooper, PhD Dr. Cooper has received personal compensation for serving as an employee of GSK. Dr. Cooper has stock in GSK.
SHILPA PATKAR No disclosure on file
Andrea Schulz No disclosure on file
Savita Anand No disclosure on file
Nicola Barnes No disclosure on file
Galeno Rojas, MD No disclosure on file
Julia Reedy No disclosure on file
Teneille Gofton, MD The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Margaret Gopaul, PhD Dr. Gopaul has nothing to disclose.
Raquel Farias-Moeller, MD Dr. Farias-Moeller has nothing to disclose.
Marissa Kellogg, MD, MPH, FAAN The institution of Dr. Kellogg has received research support from VA & DoD.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Nora Wong No disclosure on file
Krista L. Eschbach, MD The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Satish Rao No disclosure on file
David Iwanyckyj No disclosure on file
Pablo Racana No disclosure on file
Fernando Otalora No disclosure on file
Mei Lu No disclosure on file
Sally Wade No disclosure on file
Lobna A. Abdelwahab, MD Dr. Abdelwahab has nothing to disclose.
Jaahnavee Trivedi, MD Dr. Trivedi has nothing to disclose.
Aditya Chanpura Mr. Chanpura has nothing to disclose.
Yaacov Anziska, MD Dr. Anziska has nothing to disclose.
Angus Lee, DO Dr. Lee has nothing to disclose.
Jessica B. Smith, MPH Ms. Smith has nothing to disclose.
Bonnie Li Bonnie Li has received personal compensation for serving as an employee of Kaiser Permanente.
Radostina Iordanova, DO Dr. Iordanova has nothing to disclose.
Annette M. Langer-Gould, MD, PhD An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Aysun Soysal, MD Dr. Soysal has nothing to disclose.
Joshua T. Blotter, MD Dr. Blotter has nothing to disclose.
Jau-Shin Lou, MD, PhD, FAAN Dr. Lou has nothing to disclose.
Martin Stangel, MD Prof. Stangel has received personal compensation for serving as an employee of Novartis. Prof. Stangel has stock in Novartis. Prof. Stangel has received publishing royalties from a publication relating to health care.
Dominik Feuerbach No disclosure on file
Derya Shimshek No disclosure on file
Fabrizio Gasparini No disclosure on file
Ivan Galimberti No disclosure on file
Nathalie George No disclosure on file
Gisela Peraus No disclosure on file
Judit Sovago No disclosure on file
Nilufer Kale Icen, MD Dr. Kale has nothing to disclose.
Aaron M. Carlson, MD Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Daniel Pastula, MD, MHS, FAAN Dr. Pastula has nothing to disclose.
Rumyar V. Ardakani, MD Dr. Ardakani has nothing to disclose.
Sarah Kelly, PA Ms. Kelly has nothing to disclose.
Sarah Guistolisi, MD Dr. Guistolisi has nothing to disclose.
Helena Huhmar Helena Huhmar has nothing to disclose.
Olli Polo No disclosure on file
Lauri S. Soinne, MD, PhD, FAAN Dr. Soinne has nothing to disclose.
Per Sjögren Per Sjögren has nothing to disclose.
Bo Bertilson The institution of Bo Bertilson has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medect Clinical AB.
Björn Bragée Björn Bragée has nothing to disclose.
Per Hamid Ghatan No disclosure on file
Talha Ahmad Mr. Ahmad has nothing to disclose.
Sam Hooshmand, DO Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen . The institution of Dr. Hooshmand has received research support from Novartis .
Erie Gonzalez Gutierrez, MD Dr. Gonzalez Gutierrez has nothing to disclose.
Andrea Stahulak, MD Dr. Stahulak has nothing to disclose.
B. Parsons No disclosure on file
Lydia Kauffman, MD Dr. Kauffman has nothing to disclose.
Nader El Seblani, MD, PhD Dr. El Seblani has nothing to disclose.
James Grogan, MD Dr. Grogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Jikku Jose Zachariah, DO Dr. Zachariah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS, Sanofi.
Rae E. Bacharach, DO Dr. Bacharach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生.
Puneet Kochar No disclosure on file
Birol Emir, PhD No disclosure on file
Jennifer L. Orthmann Murphy, MD, PhD Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Vigil Neuroscience. Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoGlia. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. The institution of Dr. Orthmann Murphy has received research support from Fishman Family Foundation. The institution of Dr. Orthmann Murphy has received research support from Global Leukodystrophy Initiative Clinical Trial Network. The institution of Dr. Orthmann Murphy has received research support from NINDS. The institution of Dr. Orthmann Murphy has received research support from Montague Investigator Award. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Developing CME content on Neurogenetics with American Neurological Association. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Honoraria with CMSC.
Malya Sahu, MD The institution of Dr. Sahu has received research support from 好色先生 and American Brain Foundation. The institution of Dr. Sahu has received research support from Fogarty International Center.
Natalie R. Schanzer Ms. Schanzer has nothing to disclose.
Matthew Menken, MD, FACP, FAAN No disclosure on file
Gabriela A. Bou, MD Dr. Bou has nothing to disclose.
Adam Goldman-Yassen No disclosure on file
Morgan Morris Morgan Morris has nothing to disclose.
Monideep Dutt, MD Dr. Dutt has nothing to disclose.
Phaethon Philbrook No disclosure on file
Grace Gombolay, MD, FAAN The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Lindsay Rechtman The institution of Lindsay Rechtman has received research support from ATSDR.
Rana Usman Anwar Rana Usman Anwar has nothing to disclose.
Muhammad I. Yousaf, MD Dr. Yousaf has nothing to disclose.
Victoria N. Holiday, MD Dr. Holiday has nothing to disclose.
Martin E. Brown, MD Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with University of Louisville.
Mohammad R. Ghani, MD Dr. Ghani has nothing to disclose.
Heather Sevinsky Ms. Sevinsky has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Sevinsky has stock in Biohaven Pharmaceuticals.
Bharat Awsare Bharat Awsare has received personal compensation for serving as an employee of Biohaven. Bharat Awsare has or had stock in Biohaven.
Rachel Rozakis No disclosure on file
Kimberly Gentile No disclosure on file
Patricia Mydlow Patricia Mydlow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharma.
Eric Ashbrenner Eric Ashbrenner has received personal compensation for serving as an employee of Biohaven. Eric Ashbrenner has stock in Biohaven. An immediate family member of Eric Ashbrenner has stock in Biohaven.
Rachel Ham No disclosure on file
David Stock David Stock has nothing to disclose.
Irfan Qureshi, MD Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Richard Bertz Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Laurie Wagner Laurie Wagner has nothing to disclose.
Melissa Beiner Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
Stephen Kaplita No disclosure on file
Rong Yang No disclosure on file
Azim Munivar No disclosure on file
Victoria Wirtz Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has stock in Biohaven.
Mary Donohue Mary Donohue has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc.. Mary Donohue has stock in Biohaven Pharmaceuticals, Inc..
Betty Hussey No disclosure on file
Liang Lu, MD, FAAN Dr. Lu has nothing to disclose.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Lisa Cook, MD No disclosure on file
Christopher P. Rhyne, MD Dr. Rhyne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck.
Brian Jenkins, DO Dr. Jenkins has received personal compensation for serving as an employee of Abbvie. Dr. Jenkins has received personal compensation for serving as an employee of Allergan. Dr. Jenkins has received personal compensation for serving as an employee of Teva. Dr. Jenkins has received personal compensation for serving as an employee of Biohaven. Dr. Jenkins has received personal compensation for serving as an employee of Lundbeck . Dr. Jenkins has received personal compensation for serving as an employee of Amgen and Novartis. Dr. Jenkins has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Jenkins has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan . Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven . Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen and Novartis. Dr. Jenkins has stock in Prevacus. Dr. Jenkins has received intellectual property interests from a discovery or technology relating to health care.
Olivia Hughes No disclosure on file
Brett Dabruzzo, PharmD Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Merle Diamond Merle Diamond has received personal compensation for serving as an employee of Diamond Headache Clinic. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome Therapeutics. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals'. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals Industries Ltd. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome Pharma. Merle Diamond has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Merle Diamond has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmautical Industries Ltd. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck . Merle Diamond has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Headache Foundation .
Andreas Straube Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis.
Gregor Broessner Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
Xenia Hamann Xenia Hamann has received personal compensation for serving as an employee of Teva GmbH.
Charly Gaul The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of an immediate family member of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Charly Gaul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dr. Reddy. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Perfood. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reckitt-Benckiser . The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chordate. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Dr. Reddy. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Torsten Kraya, MD Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA, Novartis, Lilly. Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA, Novartis, Lilly, Hormosan, Abbvie.
Lars Oliver Neeb No disclosure on file
Sarah Cotton Sarah Cotton has nothing to disclose.
Lucy Hancock Lucy Hancock has received personal compensation for serving as an employee of Adelphi Real World.
James Jackson James Jackson has nothing to disclose.
William Whitton William Whitton has received personal compensation for serving as an employee of Adelphi Real World.
Shin J. Oh, MD, FAAN No disclosure on file
Ariel Israel No disclosure on file
Shlomo Vinker No disclosure on file
Danna Davidovici Danna Davidovici has received personal compensation for serving as an employee of Pfizer pharmaceutical LTD.
Matanya Tirosh Mr. Tirosh has received personal compensation for serving as an employee of Pfizer Pharmaceuticals Israel LTD.
Itay Fo No disclosure on file
Erel Domany Erel Domany has nothing to disclose.
Alla Shifrin, MD Dr. Shifrin has nothing to disclose.
Peter H. King, MD The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Charles E. Argoff, MD Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Fawad A. Khan, MD The institution of Dr. Khan has received research support from Amgen .
Steven P. Herzog, MD Dr. Herzog has nothing to disclose.
Ryan M. Smith, DO, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Susanne Awad Susanne Awad has received personal compensation for serving as an employee of Lundbeck.
Divya Asher Divya Asher has received personal compensation for serving as an employee of Lundbeck. Divya Asher has received personal compensation for serving as an employee of AbbVie.
Seema Soni-Brahmbhatt Seema Soni-Brahmbhatt has nothing to disclose.
Ahn Hee Seung No disclosure on file
Joachim Hipp No disclosure on file
Wi-Sun Ryu Wi-Sun Ryu has received personal compensation for serving as an employee of JLK Inc..
Christopher H. Hawkes, MD, Bsc, FRCP, FAAN Dr. Hawkes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Lauren Wilson Lauren Wilson has nothing to disclose.
Sarah Ayton No disclosure on file
Kandavadivu Umashankar Kandavadivu Umashankar has received personal compensation for serving as an employee of AbbVie.
Molly Duan Molly Duan has received personal compensation for serving as an employee of AbbVie.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Carlyn Patterson Gentile, MD The institution of Dr. Patterson Gentile has received research support from NIH/NINDS. The institution of Dr. Patterson Gentile has received research support from Children's Hospital of Philadelphia. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Annual Scientific Meeting, Scottsdale Meeting with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $5,000-$9,999 for serving as a Early Career Awardee with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $0-$499 for serving as a Research Prize Awardee and travel expense coverage with NIH Pain Consortium. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Speaker with Headache Cooperative of New England. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Awardee with 好色先生.
Christina Szperka No disclosure on file
Christina Master, MD, FAAP, CAQSM The institution of Dr. Master has received research support from NIH. The institution of Dr. Master has received research support from DoD. The institution of Dr. Master has received research support from AMSSM. The institution of Dr. Master has received research support from PA Department of Health. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care.
Caroline Gentile Kruse, MD Dr. Gentile Kruse has nothing to disclose.
Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Blanca Marquez de Prado An immediate family member of Blanca Marquez de Prado has stock in Latus Bio. An immediate family member of Blanca Marquez de Prado has received intellectual property interests from a discovery or technology relating to health care.
Nichelle Raj Nichelle Raj has nothing to disclose.
Morgan Evans Morgan Evans has nothing to disclose.
Pratishtha Panigrahi No disclosure on file
Soumyaa Das No disclosure on file
Ryan Shah Ryan Shah has nothing to disclose.
John W. Norris, MD No disclosure on file
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Katie Lucero No disclosure on file
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' 好色先生 Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical 好色先生. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research 好色先生 Social Awareness and Training In Neurosciences.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Aaron Briggs No disclosure on file
Joe Risser No disclosure on file
Joo Won Choi, MD Mr. Choi has nothing to disclose.
Stacy C. Brown, MD Dr. Brown has nothing to disclose.
Kirsten H. Jin Ms. Jin has nothing to disclose.
Normand E. Allaire No disclosure on file
Abdelrahman E. Elfaham, MBBS Dr. Elfaham has nothing to disclose.
Lara Eltous No disclosure on file
Ammar A. Jumah, MD Dr. Jumah has nothing to disclose.
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Lokesh Saini, DM Dr. Saini has nothing to disclose.
Sujatha Manjunathan, MD Sujatha Manjunathan has nothing to disclose.
Pradeep Kumar Gunasekaran No disclosure on file
Prawin Kumar No disclosure on file
Jagdish Goyal No disclosure on file
Sarbesh Tiwari Sarbesh Tiwari has nothing to disclose.
Bharat Choudhary Bharat Choudhary has nothing to disclose.
Melanie Li, MD Dr. Li has nothing to disclose.
Raissa Aoun, MD Dr. Aoun has nothing to disclose.
Rebecca Lalchan, DO Dr. Lalchan has nothing to disclose.
Sylvia A. Mohen, MD No disclosure on file
Nithisha Prasad, MD Miss Prasad has nothing to disclose.
Scott Grossman, MD Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Benjamin Brush, MD Dr. Brush has nothing to disclose.
Eddie Louie Eddie Louie has nothing to disclose.
Donato Pacione No disclosure on file
Samantha Smalley Samantha Smalley has nothing to disclose.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Lenore C. Ocava, MD No disclosure on file
Manasvi Gupta Dr. Gupta has nothing to disclose.
Ahmad Faraz No disclosure on file
Nafees Khan No disclosure on file
Meenakshi Gupta, MD No disclosure on file
Nathalie Guy Renouil, MD No disclosure on file
Shanindra De Alwis, MD, MBBS Dr. De Alwis has nothing to disclose.
Bimsara Senanayake, MD, MBBS, FRCP No disclosure on file
Anuradha Jayakody, MD Dr. Jayakody has nothing to disclose.
Mohammad H. Almomani, MD Dr. Almomani has nothing to disclose.
Camila Narvaez Caicedo, MD Dr. Narvaez Caicedo has nothing to disclose.
Chilvana V. Patel, MBBS, FAAN Dr. Patel has nothing to disclose.
Lajja N. Majmundar, MD Ms. Majmundar has nothing to disclose.
Capucine Piat, MD Dr. Piat has nothing to disclose.
Aidan Mullan Aidan Mullan has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Khaled Ghoniem, MD Dr. Ghoniem has nothing to disclose.
Pierpaolo Turcano, MD Dr. Turcano has nothing to disclose.
Adil Bharucha No disclosure on file
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Patrick J. Gillard, PharmD, MS Mr. Gillard has received personal compensation for serving as an employee of AbbVie. Mr. Gillard has stock in AbbVie.
Omolara Lawal, MD Dr. Lawal has nothing to disclose.
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Ann Gruber-Baldini No disclosure on file
Melissa A. Morales Garcia, MD Dr. Morales Garcia has nothing to disclose.
Joseph M. Savitt, MD, PhD The institution of Dr. Savitt has received research support from Bial. The institution of Dr. Savitt has received research support from UCB.
Sunita Shakya Sunita Shakya has nothing to disclose.
F. Rainer Von Coelln, MD The institution of Dr. Von Coelln has received research support from University of Maryland and Maryland State Goverment. Dr. Von Coelln has received intellectual property interests from a discovery or technology relating to health care.
Motohiro Okumura, MD Dr. Okumura has nothing to disclose.
Youhei Mukai, MD Dr. Mukai has nothing to disclose.
Reiko Saika Reiko Saika has nothing to disclose.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
James Searson Mr. Searson has nothing to disclose.
Octavian R. Adam, MD The institution of Dr. Adam has received research support from Jazz Pharmaceutical. The institution of Dr. Adam has received research support from Sage Therapeutics. The institution of Dr. Adam has received research support from Abbott Laboratories.
Jessica H. Goldstein, MD, FAAN Dr. Goldstein has nothing to disclose.
Tila Warner-Rosen No disclosure on file
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Michelle H. Tosin, PhD, RN Dr. Tosin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuraLight . The institution of Dr. Tosin has received research support from International Parkinson and Movement Disorders Society. Dr. Tosin has received personal compensation in the range of $500-$4,999 for serving as a Consultant with International Parkinson and Movement Disorders Society.
David Gonzalez David Gonzalez has nothing to disclose.
Irma Zhang Ms. Zhang has nothing to disclose.
Fernando L. Pagan, MD, FAAN Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Michelle Umali No disclosure on file
Luke D. Lovelace No disclosure on file
Michael Barry No disclosure on file
Lina Ariza Serrano, MD Dr. Ariza Serrano has nothing to disclose.
Gonul Ozay, MD Dr. Ozay has nothing to disclose.
Alexandre Mason Sharma, MD Dr. Mason Sharma has nothing to disclose.
Lana Raslan No disclosure on file
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Ingrid E. Tuxhorn, MD No disclosure on file
Esther Cubo Delgado, MD, PhD, FAAN Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Florita Valiñas No disclosure on file
Marta Allende Del Río No disclosure on file
Alvar Arnaiz-Gonzalez No disclosure on file
José Francisco Diez Pastor No disclosure on file
Alicia Olivares Gil No disclosure on file
José Miguel Ramírez Sanz No disclosure on file
Alvaro Garcia Bustillo Alvaro Garcia Bustillo has nothing to disclose.
Matthew J. Barrett, MD, FAAN The institution of Dr. Barrett has received research support from Kyowa Kirin. The institution of Dr. Barrett has received research support from NIH.
Ahmed Negida, MD, PhD Dr. Negida has nothing to disclose.
Sarah Lageman Sarah Lageman has received personal compensation in the range of $0-$499 for serving as a Content Validator of online materials with CurePSP.
Brian Berman, MD, MS, FAAN The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Aashish Batheja Mr. Batheja has nothing to disclose.
Nancy E. Bass, MD Dr. Bass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseviert.
Cindy M. Happel, RN Mrs. Happel has stock in Supernus Pharmaceutical.
Mindy Grall, PhD, NP Ms. Grall has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Ms. Grall has or had stock in Supernus.
Andrea Formella, PharmD, BCPP Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Monica Korell, MPH Ms. Korell has nothing to disclose.
Meredith Bock, MD The institution of Dr. Bock has received research support from 好色先生. The institution of Dr. Bock has received research support from Michael J Fox Foundation.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Julien Valverde Twiggs No disclosure on file
Betsy Hulme No disclosure on file
Brittany Contreras No disclosure on file
Kathleen Comyns Kathleen Comyns has nothing to disclose.
Krista Harrison No disclosure on file
Jori Fleisher, MD, MSCE, FAAN The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Melani Dizon No disclosure on file
Polly Dawkins No disclosure on file
Mateus Damiani Monteiro, MD Dr. Damiani Monteiro has nothing to disclose.
Carlos Rieder Carlos Rieder has nothing to disclose.
Arlete Hilbig, MD Arlete Hilbig, MD has nothing to disclose.
Liana Fernandez No disclosure on file
Euripedes G. Carvalho Neto, MD Dr. Carvalho Neto has nothing to disclose.
Zhao Wang Dr. Wang has received personal compensation for serving as an employee of Supernus Pharmaceuticals Inc. Dr. Wang has stock in Supernus Pharmaceuticals Inc.
Roberto Gomeni Roberto Gomeni has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Asfiha Gebre No disclosure on file
Gianpiera Ceresoli-Borroni, PhD Dr. Ceresoli-Borroni has nothing to disclose.
Jonathan Rubin, MD Dr. Rubin has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Rubin has stock in Supernus Pharmaceuticals. Dr. Rubin has stock in Atentiv. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care.
Nina F. Schor, MD, PhD, FAAN Dr. Schor has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Schor has received publishing royalties from a publication relating to health care. Dr. Schor has received personal compensation in the range of $100,000-$499,999 for serving as a Deputy Director for Intramural Research with National Institutes of Health.
Nargiza Mansurova, PhD Mrs. Mansurova has nothing to disclose.
Yakutkhon Madjidova No disclosure on file
Ramazon Boymurodov No disclosure on file
Nicole Bonsavage, MD Dr. Bonsavage has nothing to disclose.
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Alejandro Comellas No disclosure on file
Joel Kline No disclosure on file
Jeffrey Dawson Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
Nandakumar Narayanan, MD, PhD Dr. Narayanan has nothing to disclose.
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH.
Michelle Voss No disclosure on file
Steven W. Anderson, PhD Dr. Anderson has nothing to disclose.
Christina Weber Christina Weber has nothing to disclose.
Warren Darling No disclosure on file
Michael Hast Michael Hast has received personal compensation for serving as an employee of Merz Therapeutics.
Jenna Abdelhadi No disclosure on file
Andrew Szendrey No disclosure on file
Amanda Kong Amanda Kong has received personal compensation for serving as an employee of Aetion. Amanda Kong has stock in Aetion.
Rohan Shah No disclosure on file
Jordan Holmes Jordan Holmes has received personal compensation for serving as an employee of Merz Therapeutics.
Shivnaveen Bains, MD No disclosure on file
Katharine A. Henry, MD Dr. Henry has nothing to disclose.
William A. Dalrymple, MD Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REACH. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for M3. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Boxer Capital. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Capvision. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Cencora. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Lumanity. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Huntington Study Group. The institution of Dr. Dalrymple has received research support from Huntington's Disease Society of America.
Joseph Flanigan Joseph Flanigan has nothing to disclose.
Madaline B. Harrison, MD Dr. Harrison has nothing to disclose.
Renzo Figari-Jordan, MD, FAAN Dr. Figari-Jordan has nothing to disclose.
Binit Shah, MD, FAAN Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute.
Sara Trach No disclosure on file
M. Agustina Rossetti, PhD Dr. Rossetti has nothing to disclose.
James Patrie James Patrie has nothing to disclose.
Derrece K. Reid, MD No disclosure on file
Ghazal Banisadr, PhD Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Henry P. Moore, MD Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Richard D'Souza Richard DSouza has received personal compensation for serving as an employee of Amneal Pharmaceuticals. Richard DSouza has stock in Amneal Pharmaceuticals .
Xuemei Huang, MD, PhD Dr. Huang has received personal compensation for serving as an employee of NIH. Dr. Huang has received personal compensation for serving as an employee of DoD. The institution of Dr. Huang has received research support from NIH.
Anindita Deb, MD, FAAN Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Soaham D. Desai, MD, DM Dr. Desai has nothing to disclose.
Zahin Ahmed Mr. Ahmed has nothing to disclose.
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Ayushi D. Balan Miss Balan has nothing to disclose.
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Maria K. Houtchens, MD Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
Zhenyuan Wang, PhD Dr. Wang has nothing to disclose.
Hugo Chaumont No disclosure on file
Thomas DAVID No disclosure on file
Annie Lannuzel, MD Dr. Lannuzel has nothing to disclose.
Benoit Tressières No disclosure on file
Philippe Cabre Philippe Cabre has nothing to disclose.
Malak AlMojel, MD Dr. AlMojel has nothing to disclose.
Samar F. Ahmed, MD Dr. Ahmed has nothing to disclose.
Jasem Y. Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Shivam Patel, MD Mr. Patel has nothing to disclose.
Jaime Imitola, MD, FAAN The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Seamus Rafferty No disclosure on file
Laura Aquino No disclosure on file
Saloni Chadha No disclosure on file
Richard Ginocchio No disclosure on file
Brooke Cyr No disclosure on file
Joshua C. Fedorko Mr. Fedorko has nothing to disclose.
Sophia Woodson No disclosure on file
Edward J. Gettings, DO Dr. Gettings has nothing to disclose.
Chu-Yueh Guo, MD Dr. Guo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
Sylvia Klineova, MD Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Jong-Mi Lee, NP Ms. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Ms. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol meyers Squibb . Ms. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Ms. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon.
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Aljoeson Walker, MD No disclosure on file
Kinyee Fong Dr. Fong has received personal compensation for serving as an employee of Biogen. Dr. Fong has stock in Biogen.
Jason Mendoza No disclosure on file
Nicholas Belviso, PhD, PharmD Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Boyang Bian Boyang Bian has received personal compensation for serving as an employee of Biogen. Boyang Bian has stock in Biogen.
James B. Lewin, PharmD Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Sai L. Shankar, PhD, FAAN Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Manali S. Sheth, MD Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Naila Makhani, MD Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Veronika Shabanova No disclosure on file
Evangeline Wassmer, MD Dr. Wassmer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wassmer has received research support from Birmingham Children's Hospital Charity Research Foundation.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Sona Narula, MD Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
James N. Brenton, MD, FAAN Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Soe S. Mar, MD, FAAN The institution of Dr. Mar has received research support from NIH.
Francoise Durand Dubief The institution of Francoise Durand Dubief has received research support from ARSEP.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Guillaume Mathey Guillaume Mathey has nothing to disclose.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Silvia Tenembaum, MD Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. .
Robert I. Thompson-Stone, MD, FAAN Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: 好色先生 Journal that is relevant to AAN interests or activities.
Olivier Casez, MD Dr. Casez has nothing to disclose.
Clarisse Carra-Dalliere No disclosure on file
Rinze F Neuteboom Rinze F Neuteboom has nothing to disclose.
Nusrat Ahsan, MD Dr. Ahsan has nothing to disclose.
Hugo A. Arroyo, MD Dr. Arroyo has nothing to disclose.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Celine Louapre Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oculis.
Monica Margoni Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Filipe Palavra No disclosure on file
Daniela Pohl Daniela Pohl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos.
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Aurelie Ruet The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Niklas Timby No disclosure on file
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Wendy S. Vargas, MD Dr. Vargas has received personal compensation for serving as an employee of Sanofi.
Helene Verhelst No disclosure on file
Ronny Wickström No disclosure on file
Christina Azevedo, MD, FAAN Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Eugene Shapiro No disclosure on file
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Mar Tintoré, MD, PhD The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintoré, MD, PhD has received research support from Fundació La Marató de TV3. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III.
Jessica R. Fesler, MD Dr. Fesler has nothing to disclose.
Muhammad F. Raghib, MD Dr. Raghib has nothing to disclose.
Fen Bao Fen Bao has nothing to disclose.
ZL Liaquat ZL Liaquat has nothing to disclose.
Eman Dannawey Eman Dannawey has nothing to disclose.
Emily Pelc No disclosure on file
Carla E. Santiago-Martinez Ms. Santiago-Martinez has nothing to disclose.
Jacob C. Rube, MD Dr. Rube has nothing to disclose.
Evanthia Bernitsas, MD, FAAN Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Mahmoud Elkhooly, MD Dr. Elkhooly has nothing to disclose.
Ryan Hakimi, DO, FAAN Dr. Hakimi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for South Carolina Osteopathic Medical Society. Dr. Hakimi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Hakimi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurocritical Care Society. Dr. Hakimi has a non-compensated relationship as a Delegate, House of Delegates with American Medical Association that is relevant to AAN interests or activities. Dr. Hakimi has a non-compensated relationship as a Annual Meeting Course Committee Member, Board Member with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Hakimi has a non-compensated relationship as a Planning Committee, Board member, Treasurer, President-elect with American Society of Neuroimaging that is relevant to AAN interests or activities.
Dalal K. Qasem, MD Dr. Qasem has nothing to disclose.
Ilana B. Katz Sand, MD The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with 好色先生.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Michelle Fabian, MD, FAAN Dr. Fabian has nothing to disclose.
Kathryn Fitzgerald, PhD Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Sammita Satyanarayan, MD Dr. Satyanarayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Monitor. Dr. Satyanarayan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono .
Emmaculate M. Fields, NP Mrs. Fields has a non-compensated relationship as a Board of Directors and Treasurer with American Society of Neuroimaging that is relevant to AAN interests or activities.
Hannah F. Todd, MD, MPH Miss Todd has nothing to disclose.
Jonathan Yarimi, MD Dr. Yarimi has nothing to disclose.
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Nikita Shukla, MD The institution of Dr. Shukla has received research support from Roche.
Alexander Sandweiss, MD, PhD Dr. Sandweiss has nothing to disclose.
Robert L. Carruthers, MD Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Trieste Francis Miss Francis has nothing to disclose.
Heewon Hwang No disclosure on file
Dalia Rotstein, MD Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from National MS Society. Dr. Rotstein has received research support from Li Ka Shing Knowledge Institute. The institution of Dr. Rotstein has received research support from University of Toronto Division of Neurology. The institution of Dr. Rotstein has received research support from Canada's Drug Agency. The institution of Dr. Rotstein has received research support from Amgen. The institution of Dr. Rotstein has received research support from Alexion. The institution of Dr. Rotstein has received research support from Guthy Jackson Foundation .
Federico Casales No disclosure on file
Maria Burbano No disclosure on file
Alejandra Heriz No disclosure on file
Cecilia Gonzalez No disclosure on file
Jimena Miguez No disclosure on file
Ricardo Alonso Ricardo Alonso has nothing to disclose.
Berenice Silva SIlva Berenice has nothing to disclose.
Madeleine Rose No disclosure on file
Annika Anderson No disclosure on file
Stephanie Hsu Stephanie Hsu has nothing to disclose.
Cori Polonski No disclosure on file
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Yang Yu, MD Dr. Yu has nothing to disclose.
Hani Kushlaf, MD, FAAN Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion AstraZeneca Rare Disease. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst Pharmaceuticals. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics . Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus Therapeutics .
Guy J. Buckle, MD No disclosure on file
Rachel Walsh, MD Dr. Walsh has nothing to disclose.
Keith Van Haren, MD Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Joyutpal Das, MBBS Dr. Das has nothing to disclose.
Gagana K. Mallawaarachchi Mr. Mallawaarachchi has nothing to disclose.
David Rog, MBBS Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Novartis. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
Julio A. Chalela, MD Dr. Chalela has nothing to disclose.
Ron Neyens No disclosure on file
Jimmy Suh, MD Dr. Suh has received publishing royalties from a publication relating to health care.
Niren Kapoor, MD, PhD Dr. Kapoor has nothing to disclose.
Charles Andrews No disclosure on file
Megan Barra Ms. Barra has received personal compensation for serving as an employee of Marinus Pharmaceuticals.
Sri Saikumar No disclosure on file
Saloni Shah No disclosure on file
Dushyant Katariya No disclosure on file
Adrienne Lovink No disclosure on file
Henrikas Vaitkevicius, MD Dr. Vaitkevicius has received personal compensation for serving as an employee of Noema Pharmaceuticals. Dr. Vaitkevicius has stock in Noema Pharmaceuticals.
Eva Rybak, PharmD Dr. Rybak has received personal compensation for serving as an employee of Marinus Pharmaceuticals . Dr. Rybak has received stock or an ownership interest from Marinus Pharmaceuticals .
Miriam Quinlan, MD, MPH Dr. Quinlan has nothing to disclose.
Bakhtawar Ahmad, MBBS Dr. Ahmad has nothing to disclose.
Nicole Maranchick No disclosure on file
Daniela Pomar Forero, MD Ms. Pomar Forero has nothing to disclose.
Katharina M. Busl, MD, MS, FAAN Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities.
Maria J. Bruzzone, MD, FAAN Dr. Bruzzone has nothing to disclose.
Charles Peloquin No disclosure on file
Carolina B. Maciel, MD, MSCR, FAAN Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Stephan Eisenschenk, MD Dr. Eisenschenk has nothing to disclose.
Sérgio Brasil No disclosure on file
Danilo Cardim No disclosure on file
Fabio Taccone No disclosure on file
Jade Marshall No disclosure on file
Emerson Nairon No disclosure on file
DaiWai Olson The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Chiesi.
Alec Gomba No disclosure on file
Dawit Measho No disclosure on file
Lindsay McEver No disclosure on file
Brittany Doyle No disclosure on file
Richard Moberg No disclosure on file
Patricia Bacus, MD Dr. Bacus has nothing to disclose.
Khadija Jadun No disclosure on file
Zahra Haghighat, MD Dr. Haghighat has nothing to disclose.
Ima M. Ebong, MD, FAAN The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Ebong has received research support from Ad Scientiam.
Devin D. Mackay, MD, FAAN Dr. Mackay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Optum. Dr. Mackay has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms.
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Mariana Rodriguez Duran No disclosure on file
Mariam Torres Soto No disclosure on file
Andrew Pendley No disclosure on file
David Wright David Wright has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. David Wright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrocyte Pharmaceutical . David Wright has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for several defense legal firms. David Wright has stock in Astrocyte Pharmaceuticals. The institution of David Wright has received research support from NINDS. The institution of David Wright has received research support from Department of Defense. The institution of David Wright has received research support from Marcus Foundation. The institution of David Wright has received research support from Nico Corporation. The institution of David Wright has received research support from Center for Disease Control. David Wright has received intellectual property interests from a discovery or technology relating to health care.
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Gabriele Berman, MD Dr. Berman has nothing to disclose.
James Greene, MD, PhD Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology.
Sara LaHue, MD The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Longevity Impetus Grants. Dr. LaHue has received publishing royalties from a publication relating to health care.
Vanja C. Douglas, MD, FAAN Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Ori Lieberman, MD, PhD Dr. Lieberman has received research support from UCSF.
Beau B. Bruce, MD, FAAN Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
Maria E. Baldwin, MD Dr. Baldwin has nothing to disclose.
Jonathan Elmer Jonathan Elmer has received publishing royalties from a publication relating to health care.
Florian Mayr No disclosure on file
Kristen Rahall No disclosure on file
Fiona Grimson Fiona Grimson has received personal compensation for serving as an employee of UCB Pharma. Fiona Grimson has stock in UCB Pharma.
Asha Hareendran Asha Hareendran has received personal compensation for serving as an employee of UCB. Asha Hareendran has stock in UCB. Asha Hareendran has stock in Pfizer.
Monique Bastidas No disclosure on file
Michael Zikry No disclosure on file
Brandon Bauer No disclosure on file
Kelly Y. Chun, PhD Dr. Chun has nothing to disclose.
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Zaeem A. Siddiqi, MD, PhD Dr. Siddiqi has nothing to disclose.
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Cynthia Qi Cynthia Qi has received personal compensation for serving as an employee of argenx.
Allen Zhou No disclosure on file
Roger Kaprielian Roger Kaprielian has nothing to disclose.
Jason Locklin No disclosure on file
David Garcia No disclosure on file
Bhaskar Roy, MD, FAAN Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Sophie Lehnerer Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Sophie Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan.
Laïtissia AHAMADA No disclosure on file
Loic Carment Loic Carment has received personal compensation for serving as an employee of Ad Scientiam.
Kenza Drareni Kenza Drareni has nothing to disclose.
Pierre DROUIN Pierre DROUIN has received personal compensation for serving as an employee of AdScientiam.
Clarissa Gorin, Other Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
Dellini Ravindra Dellini Ravindra has received personal compensation for serving as an employee of Ad Scientiam.
Emma Touré Cuq No disclosure on file
Alizé Vives No disclosure on file
Emrah Aras No disclosure on file
Martin Keller No disclosure on file
Saad Zinai Saad Zinai has received personal compensation for serving as an employee of AD Scientiam. Saad Zinai has stock in Ad Scientiam.
Jun Goto, MD, PhD No disclosure on file
Louis Jackson, PharmD Dr. Jackson has received personal compensation for serving as an employee of Johnson and Johnson.
Jacqueline Pesa Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson.
Caroline Brethenoux No disclosure on file
Alyssa DeLuca No disclosure on file
Patrick Furey No disclosure on file
Rosario Alvarez No disclosure on file
Laura Gonzalez Quijano No disclosure on file
Alex Lorenzo No disclosure on file
Ashley E. Anderson, MD Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Zia U. Choudhry, MD, PhD Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Neelam Goyal, MD, FAAN Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Suraj Muley, MD, FAAN Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Sean C. Rose, MD, FAAN Dr. Rose has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Summit Experts. The institution of Dr. Rose has received research support from Dale Earnhardt Jr Foundation.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Andrew J. Gordon, MD Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
James M. Winkley, MD Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sanofi. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. The institution of Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amgen . Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG therapeutics. An immediate family member of Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for BMS. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for amgen . Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB . Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for J&J. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. The institution of Dr. Winkley has received research support from Noveratis. The institution of Dr. Winkley has received research support from Merck. The institution of Dr. Winkley has received research support from Sanofi. The institution of Dr. Winkley has received research support from Biogen. The institution of Dr. Winkley has received research support from Alexion.
Ema Rodrigues, Other Dr. Rodrigues has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rodrigues has stock in Alexion Pharmaceuticals.
Guido Sabatella Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Rup Tandan, MD, FRCP, FAAN Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.
Anastasia Wells, MD No disclosure on file
Chiara Pane, MD Dr. Pane has nothing to disclose.
Alessio Sarnataro, MD Dr. Sarnataro has nothing to disclose.
Nunzia Cuomo, MD Dr. Cuomo has nothing to disclose.
Angela Marsili Angela Marsili has nothing to disclose.
Giorgia Puorro Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elma Research. Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Mario Campanile No disclosure on file
Francesco Sacca, MD, FAAN Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Geoffrey L. Heyer, MD No disclosure on file
Rasha Moussallem, MD Dr. Moussallem has nothing to disclose.
Husam Al Sultani No disclosure on file
Christelle Haddad, MD Dr. Haddad has nothing to disclose.
Rocio C. Garcia Santibanez, MD, FAAN Dr. Garcia Santibanez has nothing to disclose.
Shaida Khan, DO Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Group instructor with Real CME.
Thy Nguyen, MD Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Cristina M. Ramo, MD Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Porpong Boonmak Porpong Boonmak has received personal compensation for serving as an employee of Analysis Group, Inc..
Maryia Zhdanava Maryia Zhdanava has received personal compensation for serving as an employee of Analysis Group.
Samuel Schwartzbein No disclosure on file
Qian Cai Qian Cai has received personal compensation for serving as an employee of Johnson & Johnson. Qian Cai has stock in Johnson & Johnson.
Dominic Pilon Dominic Pilon has received personal compensation for serving as an employee of Analysis Group, Inc..
Marie-Helene Lafeuille No disclosure on file
Patrick Lefebvre No disclosure on file
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Arman Cakar Arman Cakar has nothing to disclose.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Sandeep Kiri No disclosure on file
Kerrie-Anne Ho Kerrie-Anne Ho has stock in Ucb.
Carol Mansfield No disclosure on file
Anna Pierce No disclosure on file
Caroline Vass No disclosure on file
Xiaoying Liu No disclosure on file
Alex Rovira Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Alexis King Mrs. King has nothing to disclose.
Michael Blackowicz, PhD Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals.
Shirali Pandya, PhD Dr. Pandya has received personal compensation for serving as an employee of Alexion, Astra Zeneca Rare Disease. Dr. Pandya has received personal compensation for serving as an employee of Rhythm Pharmaceuticals. Dr. Pandya has stock in Sanofi. Dr. Pandya has stock in Alexion, Astra Zeneca Rare Disease.
Daniel Basoff, PharmD, RPh Dr. Basoff has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Aaron Carabajal-Johnson No disclosure on file
Philip Chan Philip Chan has nothing to disclose.
Nana Numapau Nana Numapau has received personal compensation for serving as an employee of Alexion Pharmaceutical.
Joel Arackal No disclosure on file
Jingyu Wang No disclosure on file
Jennifer Schwinn Jennifer Schwinn has received personal compensation for serving as an employee of Immunovant, Inc..
Brett Venker No disclosure on file
Paola Mina-Osorio, MD, PhD Dr. Mina-Osorio has received personal compensation for serving as an employee of Immunovant. Dr. Mina-Osorio has stock in Immunovant, Inc..
Anza B. Memon, MD, FAAN Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Jiachen Zhou No disclosure on file
SIGRID Maria NILIUS No disclosure on file
Olga Pilipczuk No disclosure on file
Anna Scowcroft Anna Scowcroft has received personal compensation for serving as an employee of UCB. Anna Scowcroft has stock in UCB.
Frank Tennigkeit, PhD Dr. Tennigkeit has received personal compensation for serving as an employee of UCB Biosciences. Dr. Tennigkeit has stock in UCB Biosciences.
Piotr Zaremba No disclosure on file
John Brandsema, MD Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CureSMA. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Thais T. Heras, Sr., MD Dr. Heras has received personal compensation for serving as an employee of UCB Pharma S.A.
Kumar Rajamani, MD, FAAN Dr. Rajamani has nothing to disclose.
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
David Morrell No disclosure on file
Guy Shechter No disclosure on file
Jeffrey Rosenfeld, MD, PhD, FAAN Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexion. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurizon. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serano/EMD. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General.
Regina Grebla No disclosure on file
Robert P. Lisak, MD, FAAN Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Rachelle Rodriguez No disclosure on file
Wesley Peters No disclosure on file
Gabrielle Geonnotti No disclosure on file
Maria Ait Tihyaty Dr. Ait Tihyaty has received personal compensation for serving as an employee of Dianthus Therapeutics.
Robert A. Joshua, MD Dr. Joshua has nothing to disclose.
Christina Marini Ms. Marini has nothing to disclose.
Julia Greenberg, MD Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities.
Sophia T. Tong Ms. Tong has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Azizi Seixas No disclosure on file
Kiril Kiprovski, MD Dr. Kiprovski has nothing to disclose.
Ricardo Osorio No disclosure on file
Elizabeth R. Gerstner, MD Dr. Gerstner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Midatech. Dr. Gerstner has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Gerstner Family Foundation. The institution of Dr. Gerstner has received research support from NCI.
Julie J. Miller, MD, PhD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npj Precision Oncology. The institution of Dr. Miller has received research support from NINDS. The institution of Dr. Miller has received research support from American Cancer Society - IRG Pilot Grant. The institution of Dr. Miller has received research support from Karyopharm. The institution of Dr. Miller has received research support from NCI. The institution of Dr. Miller has received research support from American Brain Tumor Association.
Maya Viera, Other Miss Viera has nothing to disclose.
Hetal Mistry, MD An immediate family member of Dr. Mistry has received personal compensation for serving as an employee of Regeneron.
Sasmit Sarangi, MD, MBBS The institution of Dr. Sarangi has received research support from Fore biotherapeutics.
Eric T. Wong, MD, FAAN Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Artur Menegaz de Almeida, MS Mr. Menegaz de Almeida has nothing to disclose.
Gabriel Marinheiro Dos Santos-Bezerra Gabriel Marinheiro Dos Santos-Bezerra has nothing to disclose.
Jessica Hoffmann Relvas No disclosure on file
Lucca Moreira Lopes No disclosure on file
Gustavo L. Guilherme, Sr. Mr. Guilherme has nothing to disclose.
João A. Zanette Giusti Mr. Zanette Giusti has nothing to disclose.
Paloma Oliveira No disclosure on file
Mauro André Cabral No disclosure on file
Renato Carvalho Santos No disclosure on file
Khalid Medani, MD Dr. Medani has nothing to disclose.
Patricia Viana No disclosure on file
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
John Paul Aboubechara, MD, PhD Dr. Aboubechara has nothing to disclose.
Orwa Aboud, MD, PhD Dr. Aboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aboud LLC.
Orin Bloch Orin Bloch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris Medical. Orin Bloch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BrainLab. The institution of Orin Bloch has received research support from NIH.
Han Lee An immediate family member of Han Lee has stock in Gilead.
Oliver Fiehn Oliver Fiehn has nothing to disclose.
Ruben Fragoso Ruben Fragoso has nothing to disclose.
Jonathan Riess Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Jonathan Riess has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Daiichi Sankyo. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Jonathan Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SeaGen. Jonathan Riess has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Riess has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Rawad Hodeify Rawad Hodeify has nothing to disclose.
Yin A. Liu, MD, FAAN Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Ryan Rilinger Mr. Rilinger has nothing to disclose.
Christine Cordova No disclosure on file
Andrew Dhawan, MD Dr. Dhawan has nothing to disclose.
Lubov Zeifman No disclosure on file
Catherine Garcia, MD Dr. Garcia has nothing to disclose.
Stephanie R. Knight, NP Ms. Knight has nothing to disclose.
Vinaykumar Puduvalli, MD Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics.
Carlos Kamiya-Matsuoka, MD Dr. Kamiya-Matsuoka has nothing to disclose.
Ruben Jauregui, MD Dr. Jauregui has nothing to disclose.
Mekka R. Garcia, MD Dr. Garcia has nothing to disclose.
Devorah Segal, MD, PhD Dr. Segal has nothing to disclose.
Aarushi Jain Miss Jain has nothing to disclose.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Syed Faaiz Enam, MBBS, PhD Dr. Enam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Emory University. Dr. Enam has stock in Thermeutics, LLC. Dr. Enam has received intellectual property interests from a discovery or technology relating to health care.
Mahabad Barwari Mahabad Barwari has nothing to disclose.
Aksharkumar Dobariya Aksharkumar Dobariya has nothing to disclose.
Reed Chen Reed Chen has nothing to disclose.
Ravi Bellamkonda The institution of Ravi Bellamkonda has received research support from NIH NCI. The institution of Ravi Bellamkonda has received research support from Emory University. Ravi Bellamkonda has received intellectual property interests from a discovery or technology relating to health care.
Toral Patel Toral Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Toral Patel has received intellectual property interests from a discovery or technology relating to health care.
Ankur Patel No disclosure on file
Maria A. Minor, MD Dr. Minor has nothing to disclose.
Justin T. Low, MD, PhD Dr. Low has nothing to disclose.
Gregory Chamberlin No disclosure on file
Vanessa Smith No disclosure on file
Karra Jones No disclosure on file
Kevin Stevenson No disclosure on file
William Jeck No disclosure on file
Cyrus A. Raji, MD, PhD Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Devi Veerappan Miss Veerappan has nothing to disclose.
Reena P. Thomas, MD, PhD, FAAN The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.
James T. Becker, PhD No disclosure on file
Emad Singer, MD Dr. Singer has received personal compensation for serving as an employee of MD Anderson Cancer Center.
Hebatalla M. Farouk No disclosure on file
Amr Moursi No disclosure on file
Abdelrahman R. Youssef Dr. Youssef has nothing to disclose.
Mohamed Elmallahy No disclosure on file
Hazem S. Ghaith No disclosure on file
Shrouk F. Mohamed Dr. Mohamed has nothing to disclose.
Mayowa Owolabi, MD, FAAN Dr. Owolabi has nothing to disclose.
Samantha Banks, MD Dr. Banks has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Anastasia Zekeridou, MD, PhD, FAAN The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Paul Decker Paul Decker has nothing to disclose.
Ronald Go Ronald Go has nothing to disclose.
Jithma Abeykoon Jithma Abeykoon has nothing to disclose.
Gaurav Goyal Gaurav Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Recordati. Gaurav Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Gaurav Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Electra.
Jason Young Jason Young has nothing to disclose.
Matthew Koster The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rigel. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Matthew Koster has received research support from Sobi.
Robert Vassallo Robert Vassallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Robert Vassallo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Rion. Robert Vassallo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Robert Vassallo has stock in Rion LLC. The institution of Robert Vassallo has received research support from NIH. The institution of Robert Vassallo has received research support from DOD. Robert Vassallo has received intellectual property interests from a discovery or technology relating to health care.
Jay Ryu Jay Ryu has nothing to disclose.
Caroline Davidge-Pitts No disclosure on file
Aishwarya Ravindran Aishwarya Ravindran has nothing to disclose.
Julio Sartori-Valinotti Julio Sartori-Valinotti has nothing to disclose.
N. Nora Bennani No disclosure on file
Mithun Shah No disclosure on file
Karen Rech Karen Rech has nothing to disclose.
Corrie Bach No disclosure on file
Jeanette Eckel-Passow The institution of Jeanette Eckel-Passow has received research support from NIH.
W. O. Tobin, PhD, MBBCh, BAO, FAAN Dr. Tobin has received publishing royalties from a publication relating to health care.
Nara Michaelson, MD The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Joshua A. Budhu, MD Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Budhu has received research support from BMSF. The institution of Dr. Budhu has received research support from Commonwealth Fund. The institution of Dr. Budhu has received research support from National Cancer Institute . The institution of Dr. Budhu has received research support from Memorial Sloan Kettering Cancer Center. The institution of Dr. Budhu has received research support from United Hospital Fund. Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as a Peer Reviewer with Medscape.
Anu Bakare-Okpala, MD Dr. Bakare-Okpala has nothing to disclose.
Amanda Watsula No disclosure on file
Maliheh Mohamadpour, MD Dr. Mohamadpour has nothing to disclose.
Ugonma N. Chukwueke, MD Dr. Chukwueke has nothing to disclose.
Hugo Botha, MD Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Yangyiran Xie Miss Xie has nothing to disclose.
Sukhman S. Parhar No disclosure on file
Shreya Gunda No disclosure on file
Xinran Qi No disclosure on file
Kekoa Taparra No disclosure on file
Armaan Jamal No disclosure on file
George Hung No disclosure on file
Nicholas Kikuta No disclosure on file
Adrian Bacong No disclosure on file
Gloria Kim No disclosure on file
Latha Palaniappan No disclosure on file
Malathi Srinivasan No disclosure on file
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Ibraheem Alkhawaldeh Ibraheem Alkhawaldeh has nothing to disclose.
Mostafa El Din Moawad Mostafa El Din Moawad has nothing to disclose.
Mohammad Al-Jafari No disclosure on file
Layan Darwish No disclosure on file
Amro Al-Qurm Mr. Al-Qurm has nothing to disclose.
Hamza K. Alsalhi Dr. Alsalhi has nothing to disclose.
Yasmeen Al-abdallat Yasmeen Al-abdallat has nothing to disclose.
Sadeen Zein Eddin No disclosure on file
Mahmoud Shaban Abdelgalil No disclosure on file
Safa Odeh No disclosure on file
Amira Mohamed Taha No disclosure on file
Jenan Aamar No disclosure on file
Omar Kaoud No disclosure on file
Ibrahim Serag No disclosure on file
Taha Fayad No disclosure on file
Mohammed Sadeq No disclosure on file
Khaled Albakri Mr. Albakri has nothing to disclose.
Abdulqadir Nashwan Abdulqadir Nashwan has nothing to disclose.
Julia M. Landry Ms. Landry has nothing to disclose.
Gabriella M. Bognet, Other Ms. Bognet has nothing to disclose.
Sarah Ahr No disclosure on file
Shakti Ramkissoon No disclosure on file
Michael Chan No disclosure on file
Christina Cramer No disclosure on file
Stephen B. Tatter, MD The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Adrian Laxton No disclosure on file
Jaclyn White No disclosure on file
Eric Severson No disclosure on file
Zachary Wallen No disclosure on file
Fang-Chi Hsu No disclosure on file
Glenn Lesser No disclosure on file
Roy E. Strowd III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Ryan Mott No disclosure on file
Kimberly Stogner No disclosure on file
Nabeela Nathoo, MD, PhD Dr. Nathoo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Joon H. Uhm, MD, FRCP(C), FAAN Dr. Uhm has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Lab.
Alyx B. Porter, MD, FAAN Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Julie E. Hammack, MD, FAAN Dr. Hammack has nothing to disclose.
Kurt A. Jaeckle, MD, FAAN Dr. Jaeckle has stock in Entegrion, Inc.
Maciej M. Mrugala, MD, PhD, MPH, FAAN Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Brian Crum, MD Dr. Crum has nothing to disclose.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Carl Hook No disclosure on file
Tammam Dayyoub, MD No disclosure on file
Isabella Sutherland Ms. Sutherland has nothing to disclose.
Alissa A. Thomas, MD, FAAN The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Adam Ulano No disclosure on file
Ahmad Riad Ramadan, MD Dr. Ramadan has received publishing royalties from a publication relating to health care. Dr. Ramadan has received publishing royalties from a publication relating to health care.
Diana M. Barratt, MD, MPH, FAAN Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Callahan Fusco. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Chane Socarras. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conroy Simberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Crandall & Katt. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelley Kronenberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Plakas Mannos. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marshall Denehey. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pritt & Spano. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Russo Law.
Amina Namrouti, MD Miss Namrouti has nothing to disclose.
Denis Babici, MD Dr. Babici has nothing to disclose.
Michael McDermott Michael McDermott has received personal compensation for serving as an employee of National Football League. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Zimmer Law. Michael McDermott has or had stock in Deinde Medical.Michael McDermott has or had stock in Zap-X .Michael McDermott has or had stock in Light Helmets. The institution of Michael McDermott has received research support from State of Florida. Michael McDermott has received intellectual property interests from a discovery or technology relating to health care.
Kathleen Thompson No disclosure on file
Yazmin Odia, MD, MS, MBA, FAAN Dr. Odia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimeric, part of Jazz Pharmaceuticals.
Zhi-Jian Chen, MD Dr. Chen has nothing to disclose.
Panayiotis Mitsias, MD The institution of Dr. Mitsias has received research support from European Union.
Michele Persico, MD Dr. Persico has nothing to disclose.
Jim Zhong No disclosure on file
Hui-Kuo Shu No disclosure on file
Yuliya Snyder, MD Dr. Snyder has nothing to disclose.
Bryan J. Neth, MD, PhD Dr. Neth has nothing to disclose.
Ugur Sener, MD Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Zafer Keser, MD Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Derek Johnson, MD Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix.
David N. Abarbanel, MD Dr. Abarbanel has nothing to disclose.
Rafid Mustafa, MD Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Mustafa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PicnicHealth. Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Mustafa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon Biosciences.
Jonas Paludo No disclosure on file
Stephen Ansell No disclosure on file
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Nupur Lala, MD Dr. Lala has nothing to disclose.
Matthias Karajannis No disclosure on file
Elena Pentsova, MD The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Maya S. Graham, MD The institution of Dr. Graham has received research support from the A. James and Alice B. Clark Foundation. The institution of Dr. Graham has received research support from NINDS.
Neil Sielski, MD Dr. Sielski has nothing to disclose.
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Lauren Schaff, MD, FAAN Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG, plc. The institution of Dr. Schaff has received research support from BTG, plc. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Ono.
Santosh Ramanathan, MD, FAAN No disclosure on file
Dhvani Raghupathy No disclosure on file
Sneha Lingam, MD Ms. Lingam has nothing to disclose.
Deepal P. Shah-Zamora, MD Dr. Shah-Zamora has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Winthrop Industrie. The institution of Dr. Shah-Zamora has received research support from CereGate Inc. The institution of Dr. Shah-Zamora has received research support from Amneal. The institution of Dr. Shah-Zamora has received research support from AbbVie .
Emily P. Pharr, MD, FAAN Dr. Pharr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Rakhee Vaidya No disclosure on file
Keirsyn Criss No disclosure on file
Kathryn Mercer No disclosure on file
Danielle Maracaja No disclosure on file
Konark Malhotra, MD Dr. Malhotra has nothing to disclose.
Sona Ohanyan No disclosure on file
Shahar Shelly, MD Dr. Shelly has or had stock in Remepy.
Chen Buxbaum No disclosure on file
Chris Hackett, MA Mr. Hackett has nothing to disclose.
Ariana M. Frontario, DO Dr. Frontario has nothing to disclose.
Michael E. Limia, MD Mr. Limia has nothing to disclose.
Caroline Thomas No disclosure on file
Matthew Gorris No disclosure on file
Cynthia Burns No disclosure on file
Darshil Shah, MBBS Dr. Shah has nothing to disclose.
Khushboo Verma, MBBS Dr. Verma has nothing to disclose.
Alexander Vartanov No disclosure on file
Matthew Zibelman No disclosure on file
Jonathan Toib, MD Mr. Toib has nothing to disclose.
David G. Wright, MD Dr. Wright has nothing to disclose.
Micah Sy, MD Dr. Sy has nothing to disclose.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Faisal A. Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Nicolas J. Abreu, MD Dr. Abreu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Abreu has received research support from Adult Polyglucosan Body Disease Research Foundation. The institution of Dr. Abreu has received research support from Sanofi Genzyme. The institution of Dr. Abreu has received research support from Takeda. The institution of Dr. Abreu has received research support from Sangamo. The institution of Dr. Abreu has received research support from BDSRA Foundation.
John-Ross Rizzo No disclosure on file
Todd Hudson No disclosure on file
Naim I. Haddad, MD, FAAN Dr. Haddad has nothing to disclose.
Kemar E. Green, DO Dr. Green has nothing to disclose.
Arens Taga, MD Dr. Taga has nothing to disclose.
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Haochen Wei No disclosure on file
Preetham Bachina Mr. Bachina has nothing to disclose.
Peter Kazanzides No disclosure on file
Tzu-Ching Wu, MD Dr. Wu has nothing to disclose.
Kyra O'Brien, MD Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received research support from Davos Alzheimer's Collaborative. The institution of Dr. O'Brien has received research support from Eli Lilly. The institution of Dr. O'Brien has received research support from AHRQ. The institution of Dr. O'Brien has received research support from NIA.
Jason H. Karlawish, MD No disclosure on file
Kristin Harkins No disclosure on file
MaryAnne Peifer No disclosure on file
Cameron Coykendall No disclosure on file
Melanie Kleid No disclosure on file
Robert Burke The institution of Robert Burke has received research support from National Institute on Aging, Agency for Healthcare Research and Quality, VA Health Services Research.
Judy Shea No disclosure on file
Daniel P. Ashley, MPA Mr. Ashley has nothing to disclose.
Christian Gericke, MD PhD MPH, FAAN Dr. Gericke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medicines Australia. Dr. Gericke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Australian Hospital and Healthcare Association. Dr. Gericke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Australian Government Agencies.
Meredith N. Braskie No disclosure on file
Vani Kumar Ms. Kumar has nothing to disclose.
Elizabeth Chernyak, MD Dr. Chernyak has received research support from Maimonides Research and Development Foundation . Dr. Chernyak has received research support from 好色先生 .
Nisma Hussein No disclosure on file
Lon Yin Chan No disclosure on file
Eymen Pinar No disclosure on file
Erkan Akkus No disclosure on file
Tugce Dilek No disclosure on file
Yilmaz Zindar No disclosure on file
Aysel Guzeler No disclosure on file
Huseyin Kilic No disclosure on file
Ömer Faruk Beser No disclosure on file
Fügen Cullu Cokugras No disclosure on file
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Irene Sintini, PhD Dr. Sintini has nothing to disclose.
Calvin W. Howard, MD Dr. Howard has or had stock in CogNet.Dr. Howard has received intellectual property interests from a discovery or technology relating to health care.
Ibrahim Serag, MD Dr. Serag has nothing to disclose.
Cori Polonski, MD Dr. Polonski has nothing to disclose.
Alma Ghirelli Ms. Ghirelli has nothing to disclose.
Anas Idris, MD Dr. Idris has nothing to disclose.
Babak Boroojerdi, MD Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Marc Morris, MD Dr. Morris has received personal compensation for serving as an employee of Avidity Biosciences Inc.. Dr. Morris has stock in Avidity Biosciences, Inc..
Kevin Alessandri Dr. Alessandri has received personal compensation for serving as an employee of Treefrog . Dr. Alessandri has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Treefrog.
Verena Ramirez Campos, MD Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Mario Ortega, PhD Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Juan I. Kenny, MD Dr. Kenny has nothing to disclose.
Karen Carr, PhD Dr. Carr has nothing to disclose.
Rita Singh, PharmD Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie.
Sujal Manohar, MD Dr. Manohar has nothing to disclose.
Kristen Staggers No disclosure on file
Ellen Fremion No disclosure on file
Heidi Castillo No disclosure on file
Jonathan Castillo No disclosure on file
Xiaofan Huang No disclosure on file
Aditi Sharma, MBBS Dr. Sharma has nothing to disclose.
Satish C. Rao, MD, MS Dr. Rao has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rao has stock in Takeda Pharmaceuticals.
Ana Maria Roman, MD Dr. Roman has nothing to disclose.
Justine Ker, MD Dr. Ker has nothing to disclose.
Ankur Patel, MD Ankur Patel, MD has nothing to disclose.